| | | | | II | | | |
| | | | | IV | | | |
| | | | | 1 | | | |
| | | | | 9 | | | |
| | | | | 10 | | | |
| | | | | 63 | | | |
| | | | | 64 | | | |
| | | | | 65 | | | |
| | | | | 89 | | | |
| | | | | 112 | | | |
| | | | | 118 | | | |
| | | | | 135 | | | |
| | | | | 145 | | | |
| | | | | 147 | | | |
| | | | | 158 | | | |
| | | | | 170 | | | |
| | | | | 173 | | | |
| | | | | 174 | | | |
| | | | | 175 | | | |
| | | | | F-1 | | |
| | |
截至3月31日的三個月,
|
| ||||||||||
| | |
2024
|
| | |
2023
|
| ||||||
| | |
繼任者
|
| | |
前任
|
| ||||||
運營費用: | | | | | | | | | | | | | | |
銷售,一般和行政
|
| | | $ | 4,649 | | | | | | $ | 3,841 | | |
研發
|
| | | | 5,732 | | | | | | | 9,205 | | |
或有對價公允價值變化
|
| | | | 63,769 | | | | | | | - | | |
總運營成本和費用
|
| | | | 74,150 | | | | | | | 13,046 | | |
經營虧損
|
| | | | (74,150) | | | | | | | (13,046) | | |
其他(損失)收入: | | | | | | | | | | | | | | |
可轉換票據公允價值變化
|
| | | | (87) | | | | | | | (4,657) | | |
認購證公允價值變動
|
| | | | (20,903) | | | | | | | - | | |
嵌入式遠期購買協議和衍生負債損失,淨
|
| | | | (22,917) | | | | | | | - | | |
其他淨收入
|
| | | | 39 | | | | | | | 64 | | |
其他損失總額,淨
|
| | | | (43,868) | | | | | | | (4,593) | | |
稅前損失
|
| | | | (118,018) | | | | | | | (17,639) | | |
所得稅
|
| | | | - | | | | | | | - | | |
淨虧損和綜合虧損
|
| | | $ | (118,018) | | | | | | $ | (17,639) | | |
每股基本和稀釋淨虧損
|
| | | $ | (3.17) | | | | | | $ | (0.13) | | |
用於計算每股基本和稀釋淨虧損的發行普通股加權平均股數
|
| | | | 37,268,074 | | | | | | | 138,825,356 | | |
| | |
截至12月31日的一年,
|
| ||||||||||||||||
| | |
2023
|
| |
2022
|
| |||||||||||||
| | |
前任
|
| | |
繼任者
|
| |
前任
|
| |||||||||
| | |
1月1日至
七月21 |
| | |
月22日至
十二月31 |
| |
1月1日至
十二月31 |
| |||||||||
| | | | | | | | | |
(As重述)
|
| | | | | | | |||
運營費用: | | | | | | | | | | | | | | | | | | | | |
銷售,一般和行政
|
| | | $ | 9,841 | | | | | | $ | 9,949 | | | | | $ | 13,675 | | |
研發
|
| | | | 19,803 | | | | | | | 13,243 | | | | | | 34,754 | | |
獲得在過程中的研發
|
| | | | - | | | | | | | 348,000 | | | | | | - | | |
或有對價公允價值變化
|
| | | | - | | | | | | | (52,750) | | | | | | - | | |
總運營成本和費用
|
| | | | 29,644 | | | | | | | 318,442 | | | | | | 48,429 | | |
經營虧損
|
| | | | (29,644) | | | | | | | (318,442) | | | | | | (48,429) | | |
其他(損失)收入: | | | | | | | | | | | | | | | | | | | | |
可轉換票據公允價值變化
|
| | | | (19,359) | | | | | | | - | | | | | | (4,416) | | |
認購證公允價值變動
|
| | | | - | | | | | | | 2,318 | | | | | | - | | |
嵌入式遠期購買協議和衍生負債的公允價值變化
|
| | | | (11,789) | | | | | | | (8,366) | | | | | | - | | |
其他淨收入
|
| | | | 114 | | | | | | | 536 | | | | | | 289 | | |
其他損失總額,淨
|
| | | | (31,034) | | | | | | | (5,512) | | | | | | (4,127) | | |
稅前損失
|
| | | | (60,678) | | | | | | | (323,954) | | | | | | (52,556) | | |
所得稅
|
| | | | - | | | | | | | - | | | | | | - | | |
淨虧損和綜合虧損
|
| | | $ | (60,678) | | | | | | $ | (323,954) | | | | | $ | (52,556) | | |
每股基本和稀釋淨虧損
|
| | | $ | (0.44) | | | | | | $ | (8.72) | | | | | $ | (0.38) | | |
使用的流通普通股加權平均股數
計算每股基本和稀釋淨虧損 |
| | | | 138,848,177 | | | | | | | 37,159,600 | | | | | | 138,848,177 | | |
名稱
|
| |
年齡
|
| |
擔任的職位
|
|
執行官 | | | | | | | |
馬克·福斯 | | | 53 | | | 執行長兼董事提名人 | |
查德·哦.D | | | 66 | | | 首席醫療官 | |
Alex Wilson | | | 38 | | | 執行副總裁、首席法律官兼公司秘書 | |
詹妮弗·西 | | | 40 | | | 副總裁、公司總監 | |
非雇員董事 | | | | | | | |
約斯特·費舍爾 | | | 69 | | | 董事長兼董事提名人 | |
埃里克·卡特,博士學位 | | | 72 | | | 董事提名人 | |
羅伯特·帕爾米薩諾 | | | 79 | | | 董事提名人 | |
雪萊·圖南 | | | 71 | | | 董事提名人 | |
姓名和主要職位
|
| |
年
|
| |
薪津
($) |
| |
花紅
($)(1) |
| |
股票
獎 ($)(2) |
| |
選項
獎 ($) |
| |
所有其他
補償 ($) |
| |
總
($) |
| |||||||||||||||||||||
馬克·福斯
|
| | | | 2023 | | | | | $ | 550,000 | | | | | $ | 398,750 | | | | | $ | 3,033,628 | | | | | | - | | | | | $ | - | | | | | $ | 3,982,378 | | |
執行長
|
| | | | 2022 | | | | | $ | 550,000 | | | | | $ | 577,500 | | | | | | - | | | | | $ | 3,675,662 | | | | | $ | 1,475 | | | | | $ | 4,804,637 | | |
查德·吳
|
| | | | 2023 | | | | | $ | 425,000 | | | | | $ | 136,000 | | | | | $ | 1,088,640 | | | | | | - | | | | | $ | - | | | | | $ | 1,649,640 | | |
首席醫療官
|
| | | | 2022 | | | | | $ | 425,000 | | | | | $ | 161,500 | | | | | | - | | | | | $ | 735,331 | | | | | $ | - | | | | | $ | 1,322,731 | | |
Alex Wilson
|
| | | | 2023 | | | | | $ | 366,301(3) | | | | | $ | 151,096 | | | | | $ | 882,680 | | | | | | - | | | | | $ | - | | | | | $ | 1,400,077 | | |
首席法務官
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
指定執行官
|
| |
2023年限制性股票
已授予單位(#) |
| |||
馬克·福斯
|
| | | | 279,855 | | |
查德·吳
|
| | | | 100,428 | | |
Alex Wilson
|
| | | | 81,428 | | |
| | | | | | | | | | | | | | |
期權獎勵
|
| |
股票獎勵
|
| ||||||||||||||||||||||||||||||
名稱
|
| |
格蘭特
日期 |
| |
歸屬
開始 日期 |
| |
數量
證券 底層 未行使 選項(#) 行使 |
| |
數量
證券 底層 未行使 選項(#) 不可行使 |
| |
選項
行使 價格 ($)(1) |
| |
選項
到期 日期 |
| |
數量
股份或 庫存單位 具有 尚未歸屬 (#) |
| |
市值
的單元 的股票 沒有 既得 ($)(2) |
| ||||||||||||||||||||||||
馬克·福斯
|
| | | | 11/20/19 | | | | | | 6/11/19 | | | | | | 970,588 | | | | | | - | | | | | $ | 10.00 | | | | | | 11/19/29 | | | | | | - | | | | | | - | | |
| | | | | 8/5/20 | | | | | | 7/1/20 | | | | | | 243,016 | | | | | | 81,005(3) | | | | | $ | 10.00 | | | | | | 8/4/30 | | | | | | - | | | | | | - | | |
| | | | | 9/9/21 | | | | | | 3/5/21 | | | | | | 145,666 | | | | | | 145,666(3) | | | | | $ | 10.00 | | | | | | 9/8/31 | | | | | | - | | | | | | - | | |
| | | | | 3/9/22 | | | | | | 3/9/22 | | | | | | 190,740 | | | | | | 190,740(3) | | | | | $ | 10.00 | | | | | | 3/8/32 | | | | | | - | | | | | | - | | |
| | | | | 3/9/22 | | | | | | 3/9/22 | | | | | | 97,059 | | | | | | 97,059(3) | | | | | $ | 10.00 | | | | | | 3/8/32 | | | | | | - | | | | | | - | | |
| | | | | 4/26/23 | | | | | | 4/26/23 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 279,855(4) | | | | | $ | 2,014,956 | | |
查德·吳
|
| | | | 8/23/21 | | | | | | 5/31/21 | | | | | | 72,794 | | | | | | 72,794(3) | | | | | $ | 10.00 | | | | | | 8/23/31 | | | | | | - | | | | | | - | | |
| | | | | 3/9/22 | | | | | | 3/9/22 | | | | | | 57,575 | | | | | | 57,575(3) | | | | | $ | 10.00 | | | | | | 3/8/32 | | | | | | - | | | | | | - | | |
| | | | | 4/26/23 | | | | | | 4/26/23 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 100,428(4) | | | | | $ | 723,082 | | |
Alex Wilson
|
| | | | 8/23/21 | | | | | | 8/9/21 | | | | | | 38,823 | | | | | | 38,824(3) | | | | | $ | 10.00 | | | | | | 8/23/31 | | | | | | - | | | | | | - | | |
| | | | | 10/20/21 | | | | | | 10/20/21 | | | | | | 6,328 | | | | | | 6,328(3) | | | | | $ | 10.00 | | | | | | 10/19/31 | | | | | | - | | | | | | - | | |
| | | | | 3/9/22 | | | | | | 3/9/22 | | | | | | 53,304 | | | | | | 53,305(3) | | | | | $ | 10.00 | | | | | | 3/8/32 | | | | | | - | | | | | | - | | |
| | | | | 4/26/23 | | | | | | 4/26/23 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 81,428(4) | | | | | $ | 586,282 | | |
名稱
|
| |
賺取之費用
或支付 現金 ($) |
| |
股票
獎項(美金)(1) |
| |
選項
獎 ($)(2) |
| |
所有其他
補償 ($) |
| |
總
($) |
| |||||||||||||||
朱莉·B。安德魯斯(3)
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
蘭斯·A漿果(3)
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
西蒙·布蘭克(4)
|
| | | | - | | | | | $ | 807,504 | | | | | | - | | | | | | - | | | | | $ | 807,504 | | |
埃里克·卡特(5)
|
| | | $ | 11,316 | | | | | | - | | | | | $ | 186,558 | | | | | $ | 19,040(6) | | | | | $ | 216,914 | | |
約斯特·費舍爾(7)
|
| | | $ | 17,220 | | | | | $ | 658,682 | | | | | $ | 186,558 | | | | | | - | | | | | $ | 862,460 | | |
Robert E.格蘭特(4)
|
| | | | - | | | | | $ | 3,335,262 | | | | | | - | | | | | | - | | | | | $ | 3,335,262 | | |
奧列格·格羅德年斯基(3)
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
James A.萊特曼(3)
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
維克拉姆·馬利克(4)(8)
|
| | | | - | | | | | $ | 1,161,441 | | | | | | - | | | | | | - | | | | | $ | 1,161,441 | | |
達倫·奧布萊恩(4)(9)
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
羅伯特·帕爾米薩諾(5)(10)
|
| | | $ | 11,316 | | | | | | - | | | | | $ | 186,558 | | | | | | - | | | | | $ | 197,874 | | |
Richard H.竹田(4)
|
| | | $ | 25,000 | | | | | $ | 535,691 | | | | | | - | | | | | | - | | | | | $ | 560,691 | | |
雪萊·圖南(5)
|
| | | $ | 12,300 | | | | | | - | | | | | $ | 186,558 | | | | | | - | | | | | $ | 198,858 | | |
| | |
股份單位
未投資於 財年 結束(#) |
| |
尚未行使購股權
財年末(#) |
| ||||||||||||
名稱
|
| |
ABP 2019
計劃 |
| |
ABP 2019
計劃 |
| |
2023年計劃
|
| |||||||||
西蒙·布蘭克
|
| | | | 35,221 | | | | | | 102,571 | | | | | | - | | |
埃里克·卡特
|
| | | | - | | | | | | 20,809 | | | | | | 58,851 | | |
約斯特·費舍爾
|
| | | | 60,764 | | | | | | 62,972 | | | | | | 58,851 | | |
Robert E.格蘭特
|
| | | | 272,788 | | | | | | 62,972 | | | | | | - | | |
維克拉姆·馬利克
|
| | | | 77,453 | | | | | | 109,560 | | | | | | - | | |
達倫·奧布萊恩
|
| | | | - | | | | | | - | | | | | | - | | |
羅伯特·帕爾米薩諾
|
| | | | - | | | | | | - | | | | | | 58,851 | | |
Richard H.竹田
|
| | | | 25,473 | | | | | | 62,972 | | | | | | - | | |
雪萊·圖南
|
| | | | - | | | | | | - | | | | | | 58,851 | | |
相關人士
|
| |
股份
Priveterra A級 普通股 |
| |
現金購買
價格 |
| ||||||
A1
|
| | | | 5,083,325 | | | | | $ | 35,000,000 | | |
大雄製藥公司公司
|
| | | | 714,286 | | | | | $ | 5,000,000 | | |
票據持有
|
| |
本金總額
量 |
| |||
A1(1) | | | | $ | 24,500,000.00 | | |
受益所有人的姓名和地址
|
| |
數量
股份 |
| |
%
所有權 |
| ||||||
5%持有者 | | | | | | | | | | | | | |
Priveterra Sponsor,LLC(1)
|
| | | | 3,555,000 | | | | | | 9.0% | | |
大雄製藥公司附屬實體,公司(2)
|
| | | | 6,577,604 | | | | | | 16.6% | | |
Atalaya Capital Management LP附屬實體(3)
|
| | | | 3,675,000 | | | | | | 9.3% | | |
Polar多策略主基金(4)
|
| | | | 3,675,000 | | | | | | 9.3% | | |
斯特拉思佩皇冠控股集團有限責任公司(5)
|
| | | | 2,070,081 | | | | | | 5.2% | | |
董事和執行官(6) | | | | | | | | | | | | | |
約斯特·費舍爾(7)
|
| | | | 126,359 | | | | | | * | | |
埃里克·卡特(8)
|
| | | | 34,525 | | | | | | * | | |
羅伯特·帕爾米薩諾(9)
|
| | | | 4,689,617 | | | | | | 11.9% | | |
雪萊·圖南(10)
|
| | | | 19,617 | | | | | | * | | |
馬克·福斯(11)
|
| | | | 1,870,870 | | | | | | 4.5% | | |
查德·吳(12)
|
| | | | 191,873 | | | | | | * | | |
Alex Wilson(13)
|
| | | | 138,224 | | | | | | * | | |
詹妮弗·西(14)
|
| | | | 24,087 | | | | | | * | | |
所有董事和執行官集體(8人)
|
| | | | 7,095,172 | | | | | | 17.0% | | |
| | |
證券受益
此前擁有 提供 |
| |
待售證券
本次發行 |
| |
證券受益
在此提供後擁有 |
| |||||||||||||||||||||||||||||||||||||||
註冊持有人姓名
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
百分比
|
| |
權證
|
| |
百分比
|
| ||||||||||||||||||||||||
阿德爾伯特·斯塔格(1)(2)
|
| | | | 188,819 | | | | | | - | | | | | | 188,819 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
亞歷山大·威爾遜(1)(3)
|
| | | | 278,340 | | | | | | - | | | | | | 278,340 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
阿爾法國際投資有限公司(4)
|
| | | | 1,221,153 | | | | | | - | | | | | | 1,221,153 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
安德魯·布盧門菲爾德(1)(5)
|
| | | | 38,591 | | | | | | - | | | | | | 38,591 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
查德·吳(1)(6)
|
| | | | 361,167 | | | | | | - | | | | | | 361,167 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
克里斯多福·賴斯特(1)(7)
|
| | | | 31,602 | | | | | | - | | | | | | 31,602 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
大雄公司公司(8)
|
| | | | 4,177,604 | | | | | | - | | | | | | 4,177,604 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
大雄製藥有限公司(28)
|
| | | | 31,137,150 | | | | | | - | | | | | | 31,137,150 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
牙科創新投資A BV(9)
|
| | | | 423,889 | | | | | | - | | | | | | 423,889 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
牙科創新Apus Investment BV(10)
|
| | | | 280,245 | | | | | | - | | | | | | 280,245 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
埃里克·卡特(1)(11)
|
| | | | 20,809 | | | | | | - | | | | | | 20,809 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
格雷格·布魯克斯(1)(12)
|
| | | | 115,616 | | | | | | - | | | | | | 115,616 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
醫療創業控股有限公司(13)
|
| | | | 303,076 | | | | | | - | | | | | | 303,076 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
HS管理,LP(14)
|
| | | | 122,114 | | | | | | - | | | | | | 122,114 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
約斯特·費舍爾(1)(15)
|
| | | | 124,574 | | | | | | - | | | | | | 124,574 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
JVB金融集團有限責任公司(29)
|
| | | | 400,000 | | | | | | - | | | | | | 400,000 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Longitude Venture Partners II,LP(16)
|
| | | | 467,682 | | | | | | - | | | | | | 467,682 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
馬克·福斯(1)(17)
|
| | | | 2,441,394 | | | | | | - | | | | | | 2,441,394 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
奧列格·格羅德年斯基(18)(19)(27)
|
| | | | 1,579,806 | | | | | | - | | | | | | 1,579,806 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Priveterra Sponsor,LLC(19)
|
| | | | 105,000 | | | | | | - | | | | | | 105,000 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
理察·武田(20)
|
| | | | 92,649 | | | | | | - | | | | | | 92,649 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
羅伯特·格蘭特(1)(21)
|
| | | | 335,760 | | | | | | - | | | | | | 335,760 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
| | |
證券受益
此前擁有 提供 |
| |
待售證券
本次發行 |
| |
證券受益
在此提供後擁有 |
| |||||||||||||||||||||||||||||||||||||||
註冊持有人姓名
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
百分比
|
| |
權證
|
| |
百分比
|
| ||||||||||||||||||||||||
羅伯特·帕爾米薩諾(19)(34)
|
| | | | 1,255,000 | | | | | | - | | | | | | 1,255,000 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
上海恆丹投資有限公司(22)
|
| | | | 63,498 | | | | | | - | | | | | | 63,498 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
西蒙·布蘭克(23)
|
| | | | 137,793 | | | | | | - | | | | | | 137,793 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
斯特拉思佩皇冠控股集團有限責任公司(24)
|
| | | | 2,070,081 | | | | | | - | | | | | | 2,070,081 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
維克拉姆·馬利克(19)(25)(27)
|
| | | | 1,784,889 | | | | | | 1,252,596 | | | | | | 1,784,889 | | | | | | 1,252,596 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
管道投資者 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
巴塞爾·卡恩
|
| | | | 100 | | | | | | - | | | | | | 100 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
艾德·伊納爾
|
| | | | 100 | | | | | | - | | | | | | 100 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
賈里德·克魯姆克
|
| | | | 100 | | | | | | - | | | | | | 100 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
傑森·麥克勞德
|
| | | | 100 | | | | | | - | | | | | | 100 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
傑夫·羅曼
|
| | | | 100 | | | | | | - | | | | | | 100 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
喬·塔克
|
| | | | 100 | | | | | | - | | | | | | 100 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
麥可·布朗
|
| | | | 100 | | | | | | - | | | | | | 100 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
拉傑什·古塔
|
| | | | 100 | | | | | | - | | | | | | 100 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
蒂姆·鄧
|
| | | | 100 | | | | | | - | | | | | | 100 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
托尼·達斯
|
| | | | 100 | | | | | | - | | | | | | 100 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Strathspey Crown Holdings Group,LLC的轉讓人 (26)
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
190 Canon,LLC
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
3V Corp,SL.
|
| | | | 5,045 | | | | | | - | | | | | | 5,045 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
ABJR,LLC
|
| | | | 30,831 | | | | | | - | | | | | | 30,831 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
亞當·沙夫納和瑪西·魯賓JTROS
|
| | | | 1,678 | | | | | | - | | | | | | 1,678 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
艾德麗安·斯圖爾特
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
美容整形外科英國有限公司
|
| | | | 6,124 | | | | | | - | | | | | | 6,124 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Afya(Oxshott)Limited
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
艾麗西亞·巴巴
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
阿麗莎·梅洛
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
阿馬爾·拉納瓦特
|
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
AM美容外科診所公司
|
| | | | 2,522 | | | | | | - | | | | | | 2,522 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
美國房地產與信託公司,LC FBO Andrew Russo IRA
|
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
美國房地產和信託LC FBO David A Janssen
Roth IRA |
| | | | 1,359 | | | | | | - | | | | | | 1,359 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
美國房地產和信託LC FBO克里斯汀·詹森
Roth IRA |
| | | | 1,024 | | | | | | - | | | | | | 1,024 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
美國遺產和信託LC FBO約翰·格羅斯的IRA
|
| | | | 5,101 | | | | | | - | | | | | | 5,101 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
美國房地產與信託LC FBO Joseph Barnthouse IRA
|
| | | | 3,416 | | | | | | - | | | | | | 3,416 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
艾米·韋克斯勒
|
| | | | 5,893 | | | | | | - | | | | | | 5,893 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
安德里亞·特羅弗斯
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
安德魯·J·赫普芬格
|
| | | | 2,958 | | | | | | - | | | | | | 2,958 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
安德魯·P·施瓦茨
|
| | | | 1,289 | | | | | | - | | | | | | 1,289 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
安妮塔·薩盧賈
|
| | | | 8,233 | | | | | | - | | | | | | 8,233 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
安朱爾·奧貝萊
|
| | | | 1,681 | | | | | | - | | | | | | 1,681 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
| | |
證券受益
此前擁有 提供 |
| |
待售證券
本次發行 |
| |
證券受益
在此提供後擁有 |
| |||||||||||||||||||||||||||||||||||||||
註冊持有人姓名
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
百分比
|
| |
權證
|
| |
百分比
|
| ||||||||||||||||||||||||
焦慮醫療AB
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
安東尼·卡明
|
| | | | 9,148 | | | | | | - | | | | | | 9,148 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
安東尼·西摩
|
| | | | 838 | | | | | | - | | | | | | 838 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
安東尼·楊
|
| | | | 1,663 | | | | | | - | | | | | | 1,663 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
阿西姆·皮拉查
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
芭芭拉·L斯特恩和詹姆斯·D斯特恩聯合TTEES芭芭拉·L.斯特恩信託基金
|
| | | | 1,977 | | | | | | - | | | | | | 1,977 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
巴塞爾汗
|
| | | | 4,835 | | | | | | - | | | | | | 4,835 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
BLCL Investments,LLC
|
| | | | 4,202 | | | | | | - | | | | | | 4,202 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
博阿斯·肖菲爾德
|
| | | | 3,823 | | | | | | - | | | | | | 3,823 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
博拉德家族信託基金
|
| | | | 4,455 | | | | | | - | | | | | | 4,455 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
布雷登C大步走
|
| | | | 4,063 | | | | | | - | | | | | | 4,063 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
布拉德福德·斯盧茨基
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
2004年布魯克家庭信託基金
|
| | | | 1,681 | | | | | | - | | | | | | 1,681 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
卡爾詹姆斯科爾曼
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Cast ML Investments,LTD
|
| | | | 8,879 | | | | | | - | | | | | | 8,879 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
凱薩琳·德博拉和丹尼爾·卡爾·利文
信任 |
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Cathleen Greinke生活信託基金6/2/1999
|
| | | | 1,681 | | | | | | - | | | | | | 1,681 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
塑料與重建中心。薩克拉門托外科醫生公司40.1利潤分享FBO
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Chang Family Trust UAD 7-31-89
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
查普曼·巴拉德牧師家庭信託基金
|
| | | | 4,455 | | | | | | - | | | | | | 4,455 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
查爾斯·凱斯
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
克利福德·克拉克三世
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
科佩爾特家庭生活信託基金
|
| | | | 9,459 | | | | | | - | | | | | | 9,459 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
英國化妝品解決方案有限公司
|
| | | | 4,061 | | | | | | - | | | | | | 4,061 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
克雷格·R喬利
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
柯蒂斯·E Jansen,DDS 401(K)利潤分享計劃
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
辛西婭·鄧肯
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
辛西婭·馬托西安
|
| | | | 981 | | | | | | - | | | | | | 981 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
達米安·戈德堡
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
丹尼爾·德里
|
| | | | 5,297 | | | | | | - | | | | | | 5,297 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Daniel H.韋伯
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
丹尼爾·辛德拉
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
達倫·伯特·王爾德
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
戴夫·馬丁內斯
|
| | | | 53,469 | | | | | | - | | | | | | 53,469 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
大衛·詹森
|
| | | | 504 | | | | | | - | | | | | | 504 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
David L.艾布拉姆森
|
| | | | 2,164 | | | | | | - | | | | | | 2,164 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
大衛·拉爾森
|
| | | | 1,177 | | | | | | - | | | | | | 1,177 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
大衛仕集團有限公司
|
| | | | 8,058 | | | | | | - | | | | | | 8,058 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
大衛華萊士
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
黛博拉·S巴什生活信託基金
|
| | | | 1,610 | | | | | | - | | | | | | 1,610 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
黛利拉·A阿隆索
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
| | |
證券受益
此前擁有 提供 |
| |
待售證券
本次發行 |
| |
證券受益
在此提供後擁有 |
| |||||||||||||||||||||||||||||||||||||||
註冊持有人姓名
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
百分比
|
| |
權證
|
| |
百分比
|
| ||||||||||||||||||||||||
唐納德·蒂爾曼
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
道格·福爾曼
|
| | | | 420 | | | | | | - | | | | | | 420 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
道格拉斯m。安德森信託基金
|
| | | | 4,512 | | | | | | - | | | | | | 4,512 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
道格拉斯·森德羅夫
|
| | | | 16,647 | | | | | | - | | | | | | 16,647 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
愛德華·布里特·布羅克曼
|
| | | | 8,267 | | | | | | - | | | | | | 8,267 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
伊莉莎白·尤琳
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
艾莉·簡·夏普
|
| | | | 420 | | | | | | - | | | | | | 420 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
埃里克·諾瓦克
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
埃里克·梅爾滕斯
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
歐內斯特·布拉沃
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Esther R Spear不可挽回的信託FBO Scott L.矛
|
| | | | 4,905 | | | | | | - | | | | | | 4,905 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
埃亞爾·古爾
|
| | | | 4,061 | | | | | | - | | | | | | 4,061 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Eyehold BV
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Eye-Lens Pe Ltd
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
法塔法·傑斐遜
|
| | | | 6,446 | | | | | | - | | | | | | 6,446 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
法魯克家族信託基金
|
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Findelmann & Snyder LLC
|
| | | | 2,417 | | | | | | - | | | | | | 2,417 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
弗朗西斯卡·盧波
|
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
弗朗西斯·羅特
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
弗蘭克·利斯蒂
|
| | | | 1,681 | | | | | | - | | | | | | 1,681 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
弗雷德·W小希娜
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
F維吉爾可撤銷信託
|
| | | | 3,363 | | | | | | - | | | | | | 3,363 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
加里·福斯特
|
| | | | 105,432 | | | | | | - | | | | | | 105,432 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
詹保羅·吉尼
|
| | | | 838 | | | | | | - | | | | | | 838 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Gopal Batra TREE Pooman Batra TREE Batra Living Trust
|
| | | | 1,289 | | | | | | - | | | | | | 1,289 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
戈登和唐娜·克勞福德信託UTD 8/23/77
|
| | | | 56,069 | | | | | | - | | | | | | 56,069 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
格雷格·F吸血鬼
|
| | | | 5 | | | | | | - | | | | | | 5 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
格雷格·F文斯和馬喬里·G。吸血鬼生活信託基金
|
| | | | 14 | | | | | | - | | | | | | 14 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
格雷戈里·布福德
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
格雷戈里·凱勒
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
古斯塔沃·加蘭特
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
蓋伊·劉易斯
|
| | | | 8,058 | | | | | | - | | | | | | 8,058 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
哈羅德·斯圖爾特
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
哈特姆(蒂姆)阿布-賽義德
|
| | | | 1,277 | | | | | | - | | | | | | 1,277 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
乾草堆控股有限責任公司
|
| | | | 6,446 | | | | | | - | | | | | | 6,446 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
劉海倫娜
|
| | | | 2,014 | | | | | | - | | | | | | 2,014 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
伊內斯·維爾納·拉紹夫斯基
|
| | | | 2,417 | | | | | | - | | | | | | 2,417 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Rejvest AG
|
| | | | 4,061 | | | | | | - | | | | | | 4,061 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
穆罕默德·馬赫達維
|
| | | | 981 | | | | | | - | | | | | | 981 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
不可撤銷的信託FBO安德魯·康斯坦丁
|
| | | | 2,503 | | | | | | - | | | | | | 2,503 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
| | |
證券受益
此前擁有 提供 |
| |
待售證券
本次發行 |
| |
證券受益
在此提供後擁有 |
| |||||||||||||||||||||||||||||||||||||||
註冊持有人姓名
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
百分比
|
| |
權證
|
| |
百分比
|
| ||||||||||||||||||||||||
雅各布·D施泰格帕梅拉·施泰格TE
|
| | | | 5,045 | | | | | | - | | | | | | 5,045 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
詹姆斯·希利
|
| | | | 12,612 | | | | | | - | | | | | | 12,612 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
詹姆斯·湯普森
|
| | | | 1,663 | | | | | | - | | | | | | 1,663 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
詹姆斯·韋思
|
| | | | 420 | | | | | | - | | | | | | 420 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
傑米·m·門羅生活信託基金日期:2006年3月16日
|
| | | | 1,009 | | | | | | - | | | | | | 1,009 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
揚·耶恩貝克
|
| | | | 19,340 | | | | | | - | | | | | | 19,340 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
揚·西科拉
|
| | | | 48,347 | | | | | | - | | | | | | 48,347 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
賈里德·楊格
|
| | | | 4,287 | | | | | | - | | | | | | 4,287 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
J·克里斯多福·馬莫
|
| | | | 224,243 | | | | | | - | | | | | | 224,243 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
傑夫·希利
|
| | | | 16,321 | | | | | | - | | | | | | 16,321 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
傑弗里·鮑曼
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
傑弗里·弗羅莫維茨
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
傑弗里·哈托格
|
| | | | 4,133 | | | | | | - | | | | | | 4,133 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
傑弗里·S Bobst
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
傑斯珀·伯格達爾
|
| | | | 967 | | | | | | - | | | | | | 967 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
JMR Medical LLC
|
| | | | 4,190 | | | | | | - | | | | | | 4,190 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
喬利·考夫曼·珍妮特
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
約翰·伯達爾
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
約翰·格羅斯
|
| | | | 114,067 | | | | | | - | | | | | | 114,067 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
約翰·H·約瑟夫可撤銷的信託
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
約翰·科伊
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
約翰·蒙羅
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Joseph R.穀倉屋
|
| | | | 6,656 | | | | | | - | | | | | | 6,656 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
喬琳·吉布
|
| | | | 1,261 | | | | | | - | | | | | | 1,261 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
胡安·安東尼奧·博內爾·博森
|
| | | | 1,681 | | | | | | - | | | | | | 1,681 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
朱迪思·內維特
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
鳥羽淳一
|
| | | | 8,408 | | | | | | - | | | | | | 8,408 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
卡爾·奧爾森
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
凱薩琳·尼塔
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
肯尼思·佩爾森
|
| | | | 2,556 | | | | | | - | | | | | | 2,556 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
庫羅斯·阿扎爾
|
| | | | 1,261 | | | | | | - | | | | | | 1,261 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
蘭斯·阿爾布雷希森
|
| | | | 8,233 | | | | | | - | | | | | | 8,233 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
蘭斯·庫格勒
|
| | | | 981 | | | | | | - | | | | | | 981 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
拉里·帕特森
|
| | | | 14,858 | | | | | | - | | | | | | 14,858 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Laura & Fintelmann LLC
|
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Lawless Investments PTY LTD ATF Michael Lawless
家族信託 |
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
勞倫斯·b卡岑可撤銷信託
|
| | | | 981 | | | | | | - | | | | | | 981 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
勞倫斯·格雷
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
勞倫斯·斯皮瓦克
|
| | | | 1,765 | | | | | | - | | | | | | 1,765 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
萊斯利·艾默特-巴克
|
| | | | 2,417 | | | | | | - | | | | | | 2,417 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Lindstrom Family LP 2
|
| | | | 5,297 | | | | | | - | | | | | | 5,297 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Lion Crown Partners LLC
|
| | | | 123,623 | | | | | | - | | | | | | 123,623 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
| | |
證券受益
此前擁有 提供 |
| |
待售證券
本次發行 |
| |
證券受益
在此提供後擁有 |
| |||||||||||||||||||||||||||||||||||||||
註冊持有人姓名
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
百分比
|
| |
權證
|
| |
百分比
|
| ||||||||||||||||||||||||
麗莎·阿爾比瑟
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
洛里·克萊因
|
| | | | 9,668 | | | | | | - | | | | | | 9,668 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
曼達納·阿扎爾
|
| | | | 838 | | | | | | - | | | | | | 838 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
瑪麗亞·西羅內·斯科特
|
| | | | 5,044 | | | | | | - | | | | | | 5,044 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
瑪麗·哈亞格
|
| | | | 4,061 | | | | | | - | | | | | | 4,061 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
馬克·勞
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
馬克·內斯托爾
|
| | | | 1,680 | | | | | | - | | | | | | 1,680 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
瑪麗·卡羅琳·蒙喬伊
|
| | | | 1,208 | | | | | | - | | | | | | 1,208 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
瑪麗·鄧多雷-金
|
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
瑪麗·P·盧波
|
| | | | 5,959 | | | | | | - | | | | | | 5,959 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
馬蒂亞斯·莫斯
|
| | | | 16,992 | | | | | | - | | | | | | 16,992 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
門克斯·帕特森可撤銷信託
|
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
梅雷迪思(格里芬)皮爾斯
|
| | | | 2,522 | | | | | | - | | | | | | 2,522 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Michael A. Pikos
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Michael S.施瓦茨
|
| | | | 967 | | | | | | - | | | | | | 967 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
麥可·史蒂文斯
|
| | | | 5,481 | | | | | | - | | | | | | 5,481 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
邁爾斯·阿馬里諾
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
千禧信託公司FBO Craig W. Herre
IRA |
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
明迪·伯克
|
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
米奇·C·希爾
|
| | | | 981 | | | | | | - | | | | | | 981 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
MLPF & S FBO Bradley Dykstra IRA
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
南希·施萊辛格生活信託基金日期:97年11月3日
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
NDTCO飾演監管人FBO James E Shelton IRA
|
| | | | 2,578 | | | | | | - | | | | | | 2,578 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
NDTCO飾演監管人FBO Mary P Lupo
|
| | | | 1,465 | | | | | | - | | | | | | 1,465 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
NDTCO飾演FBO保管人萬斯·湯普森(Vance Thompson)September IRA
|
| | | | 4,909 | | | | | | - | | | | | | 4,909 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
尼爾·謝爾
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
尼爾·馬丁
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
New Direction IRA,Inc. FBO麥可·艾倫·史蒂文斯
IRA |
| | | | 3,223 | | | | | | - | | | | | | 3,223 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
尼古拉斯·沃洛克
|
| | | | 2,449 | | | | | | - | | | | | | 2,449 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
諾曼·拉帕波特
|
| | | | 2,521 | | | | | | - | | | | | | 2,521 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
牡蠣灣投資公司
|
| | | | 2,417 | | | | | | - | | | | | | 2,417 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Park Ave美容手術PC利潤分享信託基金(Doug Senderoff)
|
| | | | 5,297 | | | | | | - | | | | | | 5,297 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
保羅·格拉特
|
| | | | 3,528 | | | | | | - | | | | | | 3,528 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
保羅·格利克
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
佩里·賓德
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
彼得·斯奈德
|
| | | | 5,814 | | | | | | - | | | | | | 5,814 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
菲利普·桑德曼
|
| | | | 6,198 | | | | | | - | | | | | | 6,198 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
皮爾斯特家庭信託基金
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Polycom Roth IRA FBO Stephen Wilmarth
|
| | | | 981 | | | | | | - | | | | | | 981 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Polycop Tradd IRA FBO Stephen Wilmarth
|
| | | | 2,101 | | | | | | - | | | | | | 2,101 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
| | |
證券受益
此前擁有 提供 |
| |
待售證券
本次發行 |
| |
證券受益
在此提供後擁有 |
| |||||||||||||||||||||||||||||||||||||||
註冊持有人姓名
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
百分比
|
| |
權證
|
| |
百分比
|
| ||||||||||||||||||||||||
Railay Capital Partners,LP
|
| | | | 1,681 | | | | | | - | | | | | | 1,681 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
麗貝卡·馬修斯
|
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
理察·科夫曼
|
| | | | 838 | | | | | | - | | | | | | 838 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
理察·格雷科
|
| | | | 4,473 | | | | | | - | | | | | | 4,473 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
理察·科倫塔格
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Robert E.格羅夫
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
羅伯特·弗蘭克
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
羅伯特·海曼生活信託基金
|
| | | | 8,058 | | | | | | - | | | | | | 8,058 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
小羅伯特·歐文·奧利弗
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
羅伯特·馬格斯
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
羅納德·E小理查森
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
羅納德·約翰斯頓
|
| | | | 908 | | | | | | - | | | | | | 908 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
羅恩·賈斯特
|
| | | | 4,061 | | | | | | - | | | | | | 4,061 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
羅恩·克魯格
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
羅斯·克萊文斯
|
| | | | 2,522 | | | | | | - | | | | | | 2,522 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
拉塞爾·帕爾默
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
薩賓娜·塔內賈
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
薩欽·帕里克
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
賽義夫·賈威德
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
薩米爾·沙阿
|
| | | | 2,466 | | | | | | - | | | | | | 2,466 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
桑傑·D·戈爾可撤銷生活信託基金
|
| | | | 1,765 | | | | | | - | | | | | | 1,765 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
薩凡納外科附屬部門Ld
|
| | | | 1,412 | | | | | | - | | | | | | 1,412 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
SF Investments LLC
|
| | | | 19,620 | | | | | | - | | | | | | 19,620 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
斯科特·鮑
|
| | | | 8,460 | | | | | | - | | | | | | 8,460 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Scott Baugh & Associates退休信託基金
|
| | | | 1,765 | | | | | | - | | | | | | 1,765 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
斯科特·坎尼扎羅
|
| | | | 112,105 | | | | | | - | | | | | | 112,105 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
斯科特·戈德堡家庭信託基金
|
| | | | 4,203 | | | | | | - | | | | | | 4,203 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
斯科特·帕金斯
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
肖恩·k。史密斯
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
沙赫里亞爾·馬布拉赫
|
| | | | 2,522 | | | | | | - | | | | | | 2,522 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
謝里夫·馬赫達維
|
| | | | 4,905 | | | | | | - | | | | | | 4,905 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
謝爾登·L·佩克和安吉拉·A·佩克可撤銷信託
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
雪莉·貝爾
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Sintagma Investments,SL
|
| | | | 6,769 | | | | | | - | | | | | | 6,769 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
斯皮里多拉·阿圖扎
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
史蒂芬·F·布林特
|
| | | | 6,586 | | | | | | - | | | | | | 6,586 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
史蒂芬·威爾馬斯
|
| | | | 1,401 | | | | | | - | | | | | | 1,401 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
史蒂夫·金
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
史蒂文·納森
|
| | | | 1,681 | | | | | | - | | | | | | 1,681 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
史蒂文·羅森菲爾德
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
史蒂文·羅特
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Strathspey Trust於2007年發布,Kathryn Grant(Seebold)
|
| | | | 33,418 | | | | | | - | | | | | | 33,418 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
| | |
證券受益
此前擁有 提供 |
| |
待售證券
本次發行 |
| |
證券受益
在此提供後擁有 |
| |||||||||||||||||||||||||||||||||||||||
註冊持有人姓名
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
權證
|
| |
股份
的 共同 股票 |
| |
百分比
|
| |
權證
|
| |
百分比
|
| ||||||||||||||||||||||||
Studston Limited
|
| | | | 4,061 | | | | | | - | | | | | | 4,061 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
日落島有限責任公司
|
| | | | 4,484 | | | | | | - | | | | | | 4,484 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
塔克家庭信託基金
|
| | | | 1,681 | | | | | | - | | | | | | 1,681 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
貝爾家族信託基金日期:2019年9月26日
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
The Entrust Group Inc FBO Daniel Sindelar Louis Sindelar IRA#7230012896
|
| | | | 4,028 | | | | | | - | | | | | | 4,028 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
格倫·戈德堡信託基金,DPD 2021年7月27日
|
| | | | 3,713 | | | | | | - | | | | | | 3,713 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
海倫·西奧多拉(Helen Theodora)IRR信託基金
|
| | | | 12,893 | | | | | | - | | | | | | 12,893 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
西奧多·A Pasquali
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
派屈克·G西奧多拉兒童內部收益率信託基金
|
| | | | 3,868 | | | | | | - | | | | | | 3,868 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
派屈克·G西奧多拉家族信託基金
|
| | | | 23,263 | | | | | | - | | | | | | 23,263 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
托馬斯·本德三世
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
托馬斯·哈爾巴赫
|
| | | | 4,455 | | | | | | - | | | | | | 4,455 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
托馬斯·齊卡斯
|
| | | | 25,015 | | | | | | - | | | | | | 25,015 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
純種集團有限責任公司
|
| | | | 1,170 | | | | | | - | | | | | | 1,170 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
蒂芙尼·麥科馬克
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
蒂莫西·R Herre
|
| | | | 1,611 | | | | | | - | | | | | | 1,611 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
蒂娜·阿爾斯特
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
托德·斯奈德
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
托德·祖爾克和諾埃爾·貝爾特爾森可撤銷的生活
信任 |
| | | | 2,522 | | | | | | - | | | | | | 2,522 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
風險精神資本有限責任公司
|
| | | | 3,363 | | | | | | - | | | | | | 3,363 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
****特·尼古拉斯·巴特拉
|
| | | | 1,450 | | | | | | - | | | | | | 1,450 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
弗拉基米爾·格里戈里茨
|
| | | | 2,449 | | | | | | - | | | | | | 2,449 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
溫迪·尼查明生活信託基金
|
| | | | 840 | | | | | | - | | | | | | 840 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | | | |
威廉·A·布拉奇福德
|
| | | | 4,029 | | | | | | - | | | | | | 4,029 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
William R.紳士IV
|
| | | | 805 | | | | | | - | | | | | | 805 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
威爾明頓整形外科(馬克·摩根)
|
| | | | 8,913 | | | | | | - | | | | | | 8,913 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
黃家族收入信託
|
| | | | 4,204 | | | | | | - | | | | | | 4,204 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
WRE Holdings,LP
|
| | | | 1,095 | | | | | | - | | | | | | 1,095 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
Priveterra Sponsor,LLC的轉讓人(27) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
大衛·梅雷迪思
|
| | | | 69,924 | | | | | | 58,670 | | | | | | 69,924 | | | | | | 58,670 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
強大的基金
|
| | | | 640,045 | | | | | | 433,290 | | | | | | 640,045 | | | | | | 433,290 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
銀河國際合伙人有限責任公司
|
| | | | 715,537 | | | | | | 484,396 | | | | | | 715,537 | | | | | | 484,396 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
格林哈文路資本基金1,LP
|
| | | | 163,129 | | | | | | 110,433 | | | | | | 163,129 | | | | | | 110,433 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
格林哈文路資本基金2,LP
|
| | | | 214,333 | | | | | | 145,097 | | | | | | 214,333 | | | | | | 145,097 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
帕爾米薩諾家族有限責任公司
|
| | | | 2,265,000 | | | | | | 1,760,000 | | | | | | 2,265,000 | | | | | | 1,760,000 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | |
贖回日期(期間至
令到期) |
| |
普通股的公平市場價值
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
|
=/<10.00
|
| |
11.00
|
| |
12.00
|
| |
13.00
|
| |
14.00
|
| |
15.00
|
| |
16.00
|
| |
17.00
|
| |
=/>18.00
|
| |||||||||||||||||||||||||||||
60個月
|
| | | | 0.261 | | | | | | 0.281 | | | | | | 0.297 | | | | | | 0.311 | | | | | | 0.324 | | | | | | 0.337 | | | | | | 0.348 | | | | | | 0.358 | | | | | | 0.361 | | |
57個月
|
| | | | 0.257 | | | | | | 0.277 | | | | | | 0.294 | | | | | | 0.310 | | | | | | 0.324 | | | | | | 0.337 | | | | | | 0.348 | | | | | | 0.358 | | | | | | 0.361 | | |
54個月
|
| | | | 0.252 | | | | | | 0.272 | | | | | | 0.291 | | | | | | 0.307 | | | | | | 0.322 | | | | | | 0.335 | | | | | | 0.347 | | | | | | 0.357 | | | | | | 0.361 | | |
51個月
|
| | | | 0.246 | | | | | | 0.268 | | | | | | 0.287 | | | | | | 0.304 | | | | | | 0.320 | | | | | | 0.333 | | | | | | 0.346 | | | | | | 0.357 | | | | | | 0.361 | | |
48個月
|
| | | | 0.241 | | | | | | 0.263 | | | | | | 0.283 | | | | | | 0.301 | | | | | | 0.317 | | | | | | 0.332 | | | | | | 0.344 | | | | | | 0.356 | | | | | | 0.361 | | |
45個月
|
| | | | 0.235 | | | | | | 0.258 | | | | | | 0.279 | | | | | | 0.298 | | | | | | 0.315 | | | | | | 0.330 | | | | | | 0.343 | | | | | | 0.356 | | | | | | 0.361 | | |
42個月
|
| | | | 0.228 | | | | | | 0.252 | | | | | | 0.274 | | | | | | 0.294 | | | | | | 0.312 | | | | | | 0.328 | | | | | | 0.342 | | | | | | 0.355 | | | | | | 0.361 | | |
39個月
|
| | | | 0.221 | | | | | | 0.246 | | | | | | 0.269 | | | | | | 0.290 | | | | | | 0.309 | | | | | | 0.325 | | | | | | 0.340 | | | | | | 0.354 | | | | | | 0.361 | | |
36個月
|
| | | | 0.213 | | | | | | 0.239 | | | | | | 0.263 | | | | | | 0.285 | | | | | | 0.305 | | | | | | 0.323 | | | | | | 0.339 | | | | | | 0.353 | | | | | | 0.361 | | |
33個月
|
| | | | 0.205 | | | | | | 0.232 | | | | | | 0.257 | | | | | | 0.280 | | | | | | 0.301 | | | | | | 0.320 | | | | | | 0.337 | | | | | | 0.352 | | | | | | 0.361 | | |
30個月
|
| | | | 0.196 | | | | | | 0.224 | | | | | | 0.250 | | | | | | 0.274 | | | | | | 0.297 | | | | | | 0.316 | | | | | | 0.335 | | | | | | 0.351 | | | | | | 0.361 | | |
27個月
|
| | | | 0.185 | | | | | | 0.214 | | | | | | 0.242 | | | | | | 0.268 | | | | | | 0.291 | | | | | | 0.313 | | | | | | 0.332 | | | | | | 0.350 | | | | | | 0.361 | | |
24個月
|
| | | | 0.173 | | | | | | 0.204 | | | | | | 0.233 | | | | | | 0.260 | | | | | | 0.285 | | | | | | 0.308 | | | | | | 0.329 | | | | | | 0.348 | | | | | | 0.361 | | |
21個月
|
| | | | 0.161 | | | | | | 0.193 | | | | | | 0.223 | | | | | | 0.252 | | | | | | 0.279 | | | | | | 0.304 | | | | | | 0.326 | | | | | | 0.347 | | | | | | 0.361 | | |
18個月
|
| | | | 0.146 | | | | | | 0.179 | | | | | | 0.211 | | | | | | 0.242 | | | | | | 0.271 | | | | | | 0.298 | | | | | | 0.322 | | | | | | 0.345 | | | | | | 0.361 | | |
15個月
|
| | | | 0.130 | | | | | | 0.164 | | | | | | 0.197 | | | | | | 0.230 | | | | | | 0.262 | | | | | | 0.291 | | | | | | 0.317 | | | | | | 0.342 | | | | | | 0.361 | | |
12個月
|
| | | | 0.111 | | | | | | 0.146 | | | | | | 0.181 | | | | | | 0.216 | | | | | | 0.250 | | | | | | 0.282 | | | | | | 0.312 | | | | | | 0.339 | | | | | | 0.361 | | |
9個月
|
| | | | 0.090 | | | | | | 0.125 | | | | | | 0.162 | | | | | | 0.199 | | | | | | 0.237 | | | | | | 0.272 | | | | | | 0.305 | | | | | | 0.336 | | | | | | 0.361 | | |
6個月
|
| | | | 0.065 | | | | | | 0.099 | | | | | | 0.137 | | | | | | 0.178 | | | | | | 0.219 | | | | | | 0.259 | | | | | | 0.296 | | | | | | 0.331 | | | | | | 0.361 | | |
3個月
|
| | | | 0.034 | | | | | | 0.065 | | | | | | 0.104 | | | | | | 0.150 | | | | | | 0.197 | | | | | | 0.243 | | | | | | 0.286 | | | | | | 0.326 | | | | | | 0.361 | | |
0個月
|
| | | | - | | | | | | - | | | | | | 0.042 | | | | | | 0.115 | | | | | | 0.179 | | | | | | 0.233 | | | | | | 0.281 | | | | | | 0.323 | | | | | | 0.361 | | |
| 永旺生物製藥公司 | | | | | | | |
| | | | | F-2 | | | |
| | | | | F-3 | | | |
| | | | | F-4 | | | |
| | | | | F-5 | | | |
| | | | | F-6 | | | |
| | | | | F-28 | | | |
| | | | | F-29 | | | |
| | | | | F-30 | | | |
| | | | | F-31 | | | |
| | | | | F-32 | | | |
| | | | | F-33 | | | |
| | | | | F-34 | | |
| | |
繼任者
|
| |
繼任者
|
| ||||||
| | |
3月31日,
2024 |
| |
12月31日,
2023 |
| ||||||
| | |
(未經審計)
|
| | | | | | | |||
資產
|
| | | | | | | | | | | | |
易變現資產: | | | | | | | | | | | | | |
現金及現金等價物
|
| | | $ | 1,558 | | | | | $ | 5,158 | | |
預付費用和其他易變現資產
|
| | | | 940 | | | | | | 1,064 | | |
易變現資產總額
|
| | | | 2,498 | | | | | | 6,222 | | |
財產和設備,淨值
|
| | | | 307 | | | | | | 332 | | |
經營租賃使用權資產
|
| | | | 198 | | | | | | 262 | | |
其他資產
|
| | | | 29 | | | | | | 29 | | |
總資產
|
| | | $ | 3,032 | | | | | $ | 6,845 | | |
負債和股東赤字
|
| | | | | | | | | | | | |
流動負債: | | | | | | | | | | | | | |
應付帳款
|
| | | $ | 6,523 | | | | | $ | 3,388 | | |
應計臨床試驗費用
|
| | | | 984 | | | | | | 5,128 | | |
應計報酬
|
| | | | 1,338 | | | | | | 943 | | |
遠期購買協議違約金
|
| | | | 3,000 | | | | | | - | | |
其他應計費用
|
| | | | 4,112 | | | | | | 3,590 | | |
流動負債總額
|
| | | | 15,957 | | | | | | 13,049 | | |
2024年3月31日和2023年12月31日,按公允價值計算的可轉換票據,包括關聯方金額5,087美金和0美金
|
| | | | 5,087 | | | | | | - | | |
令狀責任
|
| | | | 12,000 | | | | | | 1,447 | | |
或有對價負債
|
| | | | 168,119 | | | | | | 104,350 | | |
嵌入式遠期購買協議和衍生負債
|
| | | | 250 | | | | | | 41,043 | | |
總負債
|
| | | | 201,413 | | | | | | 159,889 | | |
承諾和意外情況 | | | | | | | | | | | | | |
股東赤字: | | | | | | | | | | | | | |
A類普通股,面值0.0001美金;授權的500,000,000股
2024年3月31日和2023年12月31日,以及38,120,288股和37,159,600股 於2024年3月31日和2023年12月31日已發行和未償還, 分別 |
| | | | 4 | | | | | | 4 | | |
借記資本公積
|
| | | | 393,235 | | | | | | 381,264 | | |
應收認購款項
|
| | | | - | | | | | | (60,710) | | |
累計赤字
|
| | | | (591,620) | | | | | | (473,602) | | |
股東赤字總額
|
| | | | (198,381) | | | | | | (153,044) | | |
負債總額和股東赤字
|
| | | $ | 3,032 | | | | | $ | 6,845 | | |
| | |
止三個月
3月31日, |
| ||||||||||
| | |
2024
|
| | |
2023
|
| ||||||
| | |
繼任者
|
| | |
前任
|
| ||||||
運營費用: | | | | | | | | | | | | | | |
銷售,一般和行政
|
| | | $ | 4,649 | | | | | | $ | 3,841 | | |
研發
|
| | | | 5,732 | | | | | | | 9,205 | | |
或有對價公允價值變化
|
| | | | 63,769 | | | | | | | - | | |
總運營成本和費用
|
| | | | 74,150 | | | | | | | 13,046 | | |
經營虧損
|
| | | | (74,150) | | | | | | | (13,046) | | |
其他(損失)收入: | | | | | | | | | | | | | | |
可轉換票據公允價值變化
|
| | | | (87) | | | | | | | (4,657) | | |
認購證公允價值變動
|
| | | | (20,903) | | | | | | | - | | |
嵌入式遠期購買協議和衍生負債的損失,
淨 |
| | | | (22,917) | | | | | | | - | | |
其他淨收入
|
| | | | 39 | | | | | | | 64 | | |
其他損失總額,淨
|
| | | | (43,868) | | | | | | | (4,593) | | |
稅前損失
|
| | | | (118,018) | | | | | | | (17,639) | | |
所得稅
|
| | | | - | | | | | | | - | | |
淨虧損和綜合虧損
|
| | | $ | (118,018) | | | | | | $ | (17,639) | | |
每股基本和稀釋淨虧損
|
| | | $ | (3.17) | | | | | | $ | (0.13) | | |
用於計算每股基本和稀釋淨虧損的發行普通股加權平均股數
|
| | | | 37,268,074 | | | | | | | 138,825,356 | | |
| | |
可換股
優先股 |
| |
普通股
|
| |
額外
實收 資本 |
| |
訂閱
應收款項 |
| |
積累
赤字 |
| |
庫藏股
|
| |
非
控制 興趣 |
| |
總
股東 赤字 |
| ||||||||||||||||||||||||||||||||||||||||||
| | |
股份
|
| |
量
|
| |
股份
|
| |
量
|
| |
股份
|
| |
量
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
截至2024年1月1日的餘額(繼任者)
|
| | | | - | | | | | $ | - | | | | | | 37,159,600 | | | | | $ | 4 | | | | | $ | 381,264 | | | | | $ | (60,710) | | | | | $ | (473,602) | | | | | | - | | | | | $ | - | | | | | $ | - | | | | | $ | (153,044) | | |
淨虧損
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | (118,018) | | | | | | - | | | | | | - | | | | | | - | | | | | | (118,018) | | |
終止遠期購買協議
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 60,710 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 60,710 | | |
發行與無現金期權行使相關的股份
|
| | | | - | | | | | | - | | | | | | 960,688 | | | | | | - | | | | | | 10,350 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 10,350 | | |
基於股票的補償費用
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 1,621 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 1,621 | | |
截至2024年3月31日的餘額(繼任者)
|
| | | | - | | | | | $ | - | | | | | | 38,120,288 | | | | | $ | 4 | | | | | $ | 393,235 | | | | | $ | - | | | | | $ | (591,620) | | | | | | - | | | | | $ | - | | | | | $ | - | | | | | $ | (198,381) | | |
截至2023年1月1日的餘額(前身)
|
| | | | 21,257,708 | | | | | $ | 137,949 | | | | | | 138,848,177 | | | | | $ | 14 | | | | | $ | 187,348 | | | | | $ | - | | | | | $ | (474,839) | | | | | | (22,821) | | | | | $ | (23) | | | | | $ | 17,087 | | | | | $ | (270,413) | | |
淨虧損
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | (17,639) | | | | | | - | | | | | | - | | | | | | - | | | | | | (17,639) | | |
基於股票的補償費用
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 1,360 | | | | | | 1,360 | | |
截至2023年3月31日的餘額(前身)
|
| | | | 21,257,708 | | | | | $ | 137,949 | | | | | | 138,848,177 | | | | | $ | 14 | | | | | $ | 187,348 | | | | | $ | - | | | | | $ | (492,478) | | | | | | (22,821) | | | | | $ | (23) | | | | | $ | 18,447 | | | | | $ | (286,692) | | |
| | |
止三個月
3月31日, |
| ||||||||||
| | |
2024
|
| | |
2023
|
| ||||||
| | |
繼任者
|
| | |
前任
|
| ||||||
經營活動產生的現金流量: | | | | | | | | | | | | | | |
淨虧損
|
| | | $ | (118,018) | | | | | | $ | (17,639) | | |
將淨虧損與經營活動中使用的淨現金進行調節的調整:
|
| | | | | | | | | | | | | |
折舊
|
| | | | 25 | | | | | | | 25 | | |
基於股票的補償費用
|
| | | | 1,621 | | | | | | | 1,360 | | |
可轉換票據公允價值變化
|
| | | | 87 | | | | | | | 4,657 | | |
認購證公允價值變動
|
| | | | 20,903 | | | | | | | - | | |
嵌入式遠期購買協議和衍生負債的損失
|
| | | | 22,917 | | | | | | | - | | |
或有對價公允價值變化
|
| | | | 63,769 | | | | | | | - | | |
經營資產和負債變化: | | | | | | | | | | | | | | |
預付費用和其他易變現資產
|
| | | | 124 | | | | | | | 39 | | |
應付帳款
|
| | | | 3,136 | | | | | | | (3,524) | | |
應計費用和其他負債
|
| | | | (3,228) | | | | | | | 3,984 | | |
其他資產及負債
|
| | | | 64 | | | | | | | 40 | | |
經營活動所用現金淨額
|
| | | | (8,600) | | | | | | | (11,058) | | |
投資活動產生的現金流量: | | | | | | | | | | | | | | |
投資活動所用現金淨額
|
| | | | - | | | | | | | - | | |
融資活動產生的現金流量: | | | | | | | | | | | | | | |
發行可轉換票據的收益
|
| | | | 5,000 | | | | | | | 6,000 | | |
融資活動提供的淨現金
|
| | | | 5,000 | | | | | | | 6,000 | | |
現金及現金等值物淨減少
|
| | | | (3,600) | | | | | | | (5,058) | | |
年初現金及現金等值物
|
| | | | 5,158 | | | | | | | 9,746 | | |
期末現金及現金等值物
|
| | | $ | 1,558 | | | | | | $ | 4,688 | | |
| | |
3月31日,
2024 |
| |
12月31日,
2023 |
| ||||||
| | |
繼任者
|
| |
繼任者
|
| ||||||
家具及固定裝置
|
| | | $ | 199 | | | | | $ | 199 | | |
設備
|
| | | | 237 | | | | | | 237 | | |
租賃物業裝修
|
| | | | 66 | | | | | | 66 | | |
物業及設備
|
| | | | 502 | | | | | | 502 | | |
累計折舊
|
| | | | (195) | | | | | | (170) | | |
財產和設備,淨值
|
| | | $ | 307 | | | | | $ | 332 | | |
| | |
3月31日,
2024 |
| |
12月31日,
2023 |
| ||||||
| | |
繼任者
|
| |
前任
|
| ||||||
法律費用
|
| | | $ | 2,325 | | | | | $ | 1,867 | | |
消費稅責任
|
| | | | 569 | | | | | | 569 | | |
經營租賃負債-短期部分
|
| | | | 205 | | | | | | 278 | | |
大雄小瓶的使用
|
| | | | 25 | | | | | | 33 | | |
剩餘其他應計費用
|
| | | | 988 | | | | | | 843 | | |
其他應計費用總額
|
| | | $ | 4,112 | | | | | $ | 3,590 | | |
截至2023年3月31日的三個月(前身)
|
| | | | | | |
淨虧損
|
| | | $ | (17,639) | | |
加權平均已發行普通股、基本股和稀釋股
|
| | | | 138,825,356 | | |
每股淨虧損,基本和稀釋
|
| | | $ | (0.13) | | |
截至2024年3月31日的三個月(繼任者)
|
| | | | | | |
淨虧損
|
| | | $ | (118,018) | | |
加權平均已發行普通股、基本股和稀釋股
|
| | | | 37,268,074 | | |
每股淨虧損,基本和稀釋
|
| | | $ | (3.17) | | |
| | |
3月31日,
2024 |
| |
3月31日,
2023 |
| ||||||
| | |
繼任者
|
| |
前任
|
| ||||||
權證
|
| | | | 8,276,085 | | | | | | - | | |
或然代價
|
| | | | 16,000,000 | | | | | | - | | |
或有創始人股份
|
| | | | 3,450,000 | | | | | | - | | |
已發行的可轉換優先股
|
| | | | - | | | | | | 21,257,708 | | |
尚未發行的可轉換優先股證
|
| | | | - | | | | | | 342,011 | | |
普通股期權和限制性股票單位
|
| | | | 5,536,898 | | | | | | 9,694,890 | | |
| | | | | 33,262,983 | | | | | | 31,294,609 | | |
|
合併中作為對價發行的股份數量
|
| | | | 16,500,000 | | |
|
與承諾融資相關的臨時可轉換票據發行的股份
|
| | | | 2,226,182 | | |
|
合併後公司普通股股數總數
|
| | | | 18,726,182 | | |
|
乘以截至收盤的Priveterra股價
|
| | | $ | 10.84 | | |
|
總
|
| | | $ | 202,992 | | |
|
或然代價之公平值
|
| | | | 125,699 | | |
|
取代股份支付獎勵
|
| | | | 13,331 | | |
|
承擔的負債
|
| | | | 125 | | |
|
總購買價格
|
| | | $ | 342,147 | | |
|
現金及現金等價物
|
| | | $ | 2,001 | | |
|
淨營運資本(不包括現金及現金等值物)
|
| | | | (16,182) | | |
|
其他資產及負債
|
| | | | 775 | | |
|
獲得在過程中的研發
|
| | | | 348,000 | | |
|
收購資產淨值
|
| | | | 334,594 | | |
|
VIE合併損失
|
| | | | 7,553 | | |
|
總購買價格
|
| | | $ | 342,147 | | |
| | | | | |
共同
股份 |
| |
共同
股票 量 |
| |
訂閱
應收 |
| |
APIC
|
| |
積累
赤字 |
| |||||||||||||||
截至2023年7月21日的Priveterra收盤股權
|
| | | | | | | 557,160 | | | | | $ | - | | | | | $ | - | | | | | $ | 5,937 | | | | | $ | (12,897) | | |
合併中作為對價發行的股份
|
| |
注1
|
| | | | 16,500,000 | | | | | | 2 | | | | | | - | | | | | | 192,189 | | | | | | - | | |
合併考慮-發行的股份
與以下相關的臨時可轉換票據 的融資承諾 |
| |
附註5
|
| | | | 2,226,182 | | | | | | - | | | | | | - | | | | | | 24,132 | | | | | | - | | |
b類創始人的股票補償
股份 |
| |
附註3
|
| | | | 6,900,000 | | | | | | 1 | | | | | | - | | | | | | 68,972 | | | | | | (68,972) | | |
遠期購買協議
|
| |
附註6
|
| | | | 6,275,000 | | | | | | 1 | | | | | | (60,710) | | | | | | 66,714 | | | | | | (38,255) | | |
發行整體衍生品
|
| |
附註6
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | (427) | | |
New Money PIPE認購協議中發行的股份
|
| |
附註6
|
| | | | 1,001,000 | | | | | | - | | | | | | - | | | | | | 10,844 | | | | | | (6,433) | | |
為承諾融資而發行的股份
|
| |
附註6
|
| | | | 3,571,429 | | | | | | - | | | | | | - | | | | | | 38,714 | | | | | | (13,714) | | |
或有創始人股份
|
| |
附註6
|
| | | | - | | | | | | - | | | | | | - | | | | | | (31,401) | | | | | | - | | |
VIE合併損失
|
| |
附註3
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | (7,553) | | |
其他雜項
|
| | | | | | | 128,829 | | | | | | - | | | | | | - | | | | | | 1,397 | | | | | | (1,397) | | |
總 | | | | | | | | 37,159,600 | | | | | $ | 4 | | | | | $ | (60,710) | | | | | $ | 377,498 | | | | | $ | (149,648) | | |
| | |
公共
|
| |
私人
|
| |
總
|
| |||||||||
已發布和未完成,2024年1月1日
|
| | | | 9,200,000 | | | | | | 5,279,999 | | | | | | 14,479,999 | | |
已行使的認購證數量
|
| | | | (4,912,867) | | | | | | (1,291,047) | | | | | | (6,203,914) | | |
已發布和未完成,2024年3月31日
|
| | | | 4,287,133 | | | | | | 3,988,952 | | | | | | 8,276,085 | | |
| | |
可換股
注意到 (3級) |
| |
令
負債 (1級) |
| |
特遣隊
審議 (3級) |
| |
嵌入式
遠期購買 協議和 使整個 衍生物 (3級) |
| ||||||||||||
繼任者 | | | | | | | | | | | | | | | | | | | | | | | | | |
餘額,2024年1月1日
|
| | | $ | - | | | | | $ | 1,447 | | | | | $ | 104,350 | | | | | $ | 41,043 | | |
發行可換股票據
|
| | | | 5,000 | | | | | | - | | | | | | - | | | | | | - | | |
公平值變動
|
| | | | 87 | | | | | | 20,903 | | | | | | 63,769 | | | | | | (413) | | |
令式無現金練習
|
| | | | - | | | | | | (10,350) | | | | | | - | | | | | | - | | |
終止遠期購買協議
|
| | | | - | | | | | | - | | | | | | - | | | | | | (40,380) | | |
終止遠期購買協議
|
| | | $ | 5,087 | | | | | $ | 12,000 | | | | | $ | 168,119 | | | | | $ | 250 | | |
| 各財年的最低租賃付款額 | | | | | | | |
|
2024
|
| | | $ | 213 | | |
|
未來最低租賃付款總額
|
| | | | 213 | | |
|
減:推定利息
|
| | | | (8) | | |
|
租賃付款現值
|
| | | | 205 | | |
|
減:流動部分(包括在其他應計費用中)
|
| | | | (205) | | |
|
非流動經營租賃負債
|
| | | $ | - | | |
|
經營租賃使用權資產
|
| | | $ | 198 | | |
|
剩餘租期(年)
|
| | | | 0.7 | | |
|
貼現率
|
| | | | 10% | | |
| | |
止三個月
3月31日, |
| |||||||||
| | |
2024
|
| |
2023
|
| ||||||
| | |
繼任者
|
| |
前任
|
| ||||||
經營租賃成本
|
| | | $ | 43 | | | | | $ | 60 | | |
經營租賃支付的現金
|
| | | | 80 | | | | | | 77 | | |
| | |
3月31日,
2024 |
| |
12月31日,
2023 |
| ||||||
| | |
(未經審計)
|
| | | | | | | |||
已發行和未行使的股票期權
|
| | | | 4,545,332 | | | | | | 3,846,972 | | |
限制性股票單位(未歸屬)
|
| | | | 991,566 | | | | | | 1,012,994 | | |
股票激勵計劃下可供未來發行的股票
|
| | | | 3,347,924 | | | | | | 3,536,710 | | |
權證
|
| | | | 8,276,085 | | | | | | 14,479,999 | | |
或然代價
|
| | | | 16,000,000 | | | | | | 16,000,000 | | |
保留普通股總數
|
| | | | 33,160,907 | | | | | | 38,876,675 | | |
| | |
數量
股份 |
| |
加權
平均 行使 價格 |
| ||||||
繼任者 | | | | | | | | | | | | | |
傑出,2024年1月1日
|
| | | | 3,515,219 | | | | | $ | 10.00 | | |
授出購股權
|
| | | | - | | | | | | - | | |
期權被沒收
|
| | | | - | | | | | | - | | |
優秀,2024年3月31日
|
| | | | 3,515,219 | | | | | | 10.00 | | |
可撤銷,2024年3月31日
|
| | | | - | | | | | $ | - | | |
| | |
數量
股份 |
| |
加權
平均 授出日期 公平值 |
| ||||||
繼任者 | | | | | | | | | | | | | |
傑出,2024年1月1日
|
| | | | 1,012,994 | | | | | $ | 10.84 | | |
授予
|
| | | | - | | | | | | - | | |
既得
|
| | | | - | | | | | | - | | |
沒收
|
| | | | (21,428) | | | | | | 10.84 | | |
優秀,2024年3月31日
|
| | | | 991,566 | | | | | $ | 10.84 | | |
| | |
數量
股份 |
| |
加權
平均 行使 價格 |
| ||||||
傑出,2024年1月1日
|
| | | | 331,753 | | | | | $ | 5.47 | | |
授出購股權
|
| | | | 698,360 | | | | | | 13.26 | | |
期權被沒收
|
| | | | - | | | | | | - | | |
優秀,2024年3月31日
|
| | | | 1,030,113 | | | | | $ | 10.75 | | |
可撤銷,2024年3月31日
|
| | | | - | | | | | $ | - | | |
| | |
止三個月
3月31日, |
| |||
| | |
2024
|
| |
2023
|
|
預期波幅
|
| |
47% - 50%
|
| |
74% - 80%
|
|
無風險利率
|
| |
4.1% - 4.3%
|
| |
3.61% - 3.66%
|
|
預期壽命(年)
|
| |
5.27- 6.25
|
| |
5.50- 6.25
|
|
預期股息率
|
| |
-
|
| |
-
|
|
| | |
繼任者
|
| | |
前任
|
| ||||||
| | |
12月31日,
2023 |
| | |
12月31日,
2022 |
| ||||||
資產
|
| | | | | | | | | | | | | |
易變現資產: | | | | | | | | | | | | | | |
現金及現金等價物
|
| | | $ | 5,158 | | | | | | $ | 9,746 | | |
預付費用和其他易變現資產
|
| | | | 1,064 | | | | | | | 92 | | |
易變現資產總額
|
| | | | 6,222 | | | | | | | 9,838 | | |
財產和設備,淨值
|
| | | | 332 | | | | | | | 431 | | |
經營租賃使用權資產
|
| | | | 262 | | | | | | | 475 | | |
其他資產
|
| | | | 29 | | | | | | | 34 | | |
總資產
|
| | | $ | 6,845 | | | | | | $ | 10,778 | | |
負債、可轉換股票和股東赤字
|
| | | | | | | | | | | | | |
流動負債: | | | | | | | | | | | | | | |
應付帳款
|
| | | $ | 3,388 | | | | | | $ | 7,805 | | |
應計臨床試驗費用
|
| | | | 5,128 | | | | | | | 2,051 | | |
應計報酬
|
| | | | 943 | | | | | | | 1,112 | | |
其他應計費用
|
| | | | 3,590 | | | | | | | 740 | | |
按公允價值計算的可轉換票據的當前部分,包括關聯方金額
2023年12月31日和2022年12月31日分別為0美金和38,834美金 |
| | | | - | | | | | | | 70,866 | | |
流動負債總額
|
| | | | 13,049 | | | | | | | 82,574 | | |
按公允價值計算的可轉換票據,包括關聯方金額0美金和23,132美金,
分別於2023年12月31日和2022年12月31日 |
| | | | - | | | | | | | 60,426 | | |
經營租賃負債
|
| | | | - | | | | | | | 242 | | |
令狀責任
|
| | | | 1,447 | | | | | | | - | | |
或有對價負債
|
| | | | 104,350 | | | | | | | - | | |
嵌入式遠期購買協議和衍生負債
|
| | | | 41,043 | | | | | | | - | | |
總負債
|
| | | | 159,889 | | | | | | | 143,242 | | |
承諾和意外情況 | | | | | | | | | | | | | | |
可連續發行的可轉換優先股,面值0.0001美金; 44,666,035股
截至2022年12月31日授權; 21,257,708股已發行和發行股票 2022年12月31日; 2022年12月31日清算優先權為141,920美金 |
| | | | - | | | | | | | 137,949 | | |
股東赤字: | | | | | | | | | | | | | | |
永旺Bizerma,Inc.股東赤字:
|
| | | | | | | | | | | | | |
A類普通股,面值0.0001美金; 2023年12月31日和2022年12月31日,授權500,00,000股和207,450,050股,已發行37,159,600股和138,848,177股,發行37,159,600股和138,825,356股
|
| | | | 4 | | | | | | | 14 | | |
借記資本公積
|
| | | | 381,264 | | | | | | | 187,348 | | |
應收認購款項
|
| | | | (60,710) | | | | | | | - | | |
累計赤字
|
| | | | (473,602) | | | | | | | (474,839) | | |
庫存股,按成本計算,2023年12月31日和12月31日為0股和22,821股,
分別為2022年 |
| | | | - | | | | | | | (23) | | |
道達爾永旺Bizerma,Inc.股東赤字
|
| | | | (153,044) | | | | | | | (287,500) | | |
非控股權益
|
| | | | - | | | | | | | 17,087 | | |
股東赤字總額
|
| | | | (153,044) | | | | | | | (270,413) | | |
負債總額、可轉換優先股和股東赤字
|
| | | $ | 6,845 | | | | | | $ | 10,778 | | |
| | |
止年度
12月31日, |
| ||||||||||||||||
| | |
2023
|
| |
2022
|
| |||||||||||||
| | |
前任
|
| | |
繼任者
|
| |
前任
|
| |||||||||
| | |
1月1日至
七月21 |
| | |
月22日至
十二月31 |
| |
1月1日至
十二月31 |
| |||||||||
| | | | | | | | | |
(As重述)
|
| | | | | | | |||
運營費用: | | | | | | | | | | | | | | | | | | | | |
銷售,一般和行政
|
| | | $ | 9,841 | | | | | | $ | 9,949 | | | | | $ | 13,675 | | |
研發
|
| | | | 19,803 | | | | | | | 13,243 | | | | | | 34,754 | | |
獲得在過程中的研發
|
| | | | - | | | | | | | 348,000 | | | | | | - | | |
或有對價公允價值變化
|
| | | | - | | | | | | | (52,750) | | | | | | - | | |
總運營成本和費用
|
| | | | 29,644 | | | | | | | 318,442 | | | | | | 48,429 | | |
經營虧損
|
| | | | (29,644) | | | | | | | (318,442) | | | | | | (48,429) | | |
其他(損失)收入: | | | | | | | | | | | | | | | | | | | | |
可轉換票據公允價值變化
|
| | | | (19,359) | | | | | | | - | | | | | | (4,416) | | |
認購證公允價值變動
|
| | | | - | | | | | | | 2,318 | | | | | | - | | |
嵌入式遠期購買協議和衍生負債的公允價值變化
|
| | | | (11,789) | | | | | | | (8,366) | | | | | | - | | |
其他淨收入
|
| | | | 114 | | | | | | | 536 | | | | | | 289 | | |
其他損失總額,淨
|
| | | | (31,034) | | | | | | | (5,512) | | | | | | (4,127) | | |
稅前損失
|
| | | | (60,678) | | | | | | | (323,954) | | | | | | (52,556) | | |
所得稅
|
| | | | - | | | | | | | - | | | | | | - | | |
淨虧損和綜合虧損
|
| | | $ | (60,678) | | | | | | $ | (323,954) | | | | | $ | (52,556) | | |
每股基本和稀釋淨虧損
|
| | | $ | (0.44) | | | | | | $ | (8.72) | | | | | $ | (0.38) | | |
用於計算每股基本和稀釋淨虧損的發行普通股加權平均股數
|
| | | | 138,848,177 | | | | | | | 37,159,600 | | | | | | 138,848,177 | | |
| | |
可換股
優先股 |
| |
普通股
|
| |
額外
實收 資本 |
| |
訂閱
應收款項 |
| |
積累
赤字 |
| |
庫藏股
|
| |
非
控制 興趣 |
| |
總
股東 赤字 |
| ||||||||||||||||||||||||||||||||||||||||||
| | |
股份
|
| |
量
|
| |
股份
|
| |
量
|
| |
股份
|
| |
量
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
截至2023年1月1日的餘額(前身)
|
| | | | 21,257,708 | | | | | $ | 137,949 | | | | | | 138,848,177 | | | | | $ | 14 | | | | | $ | 187,348 | | | | | $ | - | | | | | $ | (474,839) | | | | | | (22,821) | | | | | $ | (23) | | | | | $ | 17,087 | | | | | $ | (270,413) | | |
淨虧損
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | (60,678) | | | | | | - | | | | | | - | | | | | | - | | | | | | (60,678) | | |
基於股票的補償費用
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 3,235 | | | | | | 3,235 | | |
因授權令修改而導致的債務消滅
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 17,036 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 17,036 | | |
截至2023年7月21日的餘額(前身)
|
| | | | 21,257,708 | | | | | $ | 137,949 | | | | | | 138,848,177 | | | | | $ | 14 | | | | | $ | 204,384 | | | | | $ | - | | | | | $ | (535,517) | | | | | | (22,821) | | | | | $ | (23) | | | | | $ | 20,322 | | | | | $ | (310,820) | | |
| | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
截至2023年7月22日的餘額(繼任者)(重述)
|
| | | | - | | | | | $ | - | | | | | | 37,159,600 | | | | | $ | 4 | | | | | $ | 377,498 | | | | | $ | (60,710) | | | | | $ | (149,648) | | | | | | - | | | | | $ | - | | | | | $ | - | | | | | $ | 167,144 | | |
淨虧損(重述)
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | (323,954) | | | | | | - | | | | | | - | | | | | | - | | | | | | (323,954) | | |
基於股票的補償費用
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 3,766 | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 3,766 | | |
截至2023年12月31日的餘額(繼任者)(重述)
|
| | | | - | | | | | $ | - | | | | | | 37,159,600 | | | | | $ | 4 | | | | | $ | 381,264 | | | | | $ | (60,710) | | | | | $ | (473,602) | | | | | | - | | | | | $ | - | | | | | $ | - | | | | | $ | (153,044) | | |
截至2022年1月1日的餘額(前身)
|
| | | | 21,257,708 | | | | | $ | 137,949 | | | | | | 138,848,177 | | | | | $ | 14 | | | | | $ | 187,348 | | | | | $ | - | | | | | $ | (422,283) | | | | | | (22,821) | | | | | $ | (23) | | | | | $ | 11,120 | | | | | $ | (223,824) | | |
淨虧損
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | (52,556) | | | | | | - | | | | | | - | | | | | | - | | | | | | (52,556) | | |
基於股票的補償費用
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | 5,967 | | | | | | 5,967 | | |
截至2022年12月31日的餘額(前身)
|
| | | | 21,257,708 | | | | | $ | 137,949 | | | | | | 138,848,177 | | | | | $ | 14 | | | | | $ | 187,348 | | | | | $ | - | | | | | $ | (474,839) | | | | | | (22,821) | | | | | $ | (23) | | | | | $ | 17,087 | | | | | $ | (270,413) | | |
| | |
止年度
12月31日, |
| ||||||||||||||||
| | |
2023
|
| |
2022
|
| |||||||||||||
| | |
前任
|
| | |
繼任者
|
| |
前任
|
| |||||||||
| | |
1月1日至
七月21 |
| | |
月22日至
十二月31 |
| |
1月1日至
十二月31 |
| |||||||||
| | | | | | | | | |
(As重述)
|
| | | | | | | |||
經營活動產生的現金流量: | | | | | | | | | | | | | | | | | | | | |
淨虧損
|
| | | $ | (60,678) | | | | | | $ | (323,954) | | | | | $ | (52,556) | | |
將淨虧損與經營活動中使用的淨現金進行調節的調整:
|
| | | | | | | | | | | | | | | | | | | |
折舊
|
| | | | 54 | | | | | | | 45 | | | | | | 68 | | |
遞延發行成本的註銷
|
| | | | - | | | | | | | - | | | | | | 331 | | |
基於股票的補償費用
|
| | | | 3,235 | | | | | | | 3,766 | | | | | | 5,892 | | |
核銷已獲得的在制品研發
|
| | | | - | | | | | | | 348,000 | | | | | | - | | |
可轉換票據公允價值變化
|
| | | | 19,359 | | | | | | | - | | | | | | 4,416 | | |
認購證公允價值變動
|
| | | | - | | | | | | | (2,318) | | | | | | - | | |
嵌入式遠期購買協議的公允價值變化
和衍生負債 |
| | | | 11,789 | | | | | | | 8,366 | | | | | | - | | |
或有對價公允價值變化
|
| | | | - | | | | | | | (52,750) | | | | | | - | | |
其他
|
| | | | - | | | | | | | - | | | | | | (3) | | |
經營資產和負債變化: | | | | | | | | | | | | | | | | | | | | |
預付費用和其他易變現資產
|
| | | | 36 | | | | | | | (693) | | | | | | (66) | | |
應付帳款
|
| | | | (248) | | | | | | | (4,342) | | | | | | 6,613 | | |
應計費用和其他負債
|
| | | | 4,736 | | | | | | | (2,204) | | | | | | (105) | | |
其他資產及負債
|
| | | | (28) | | | | | | | 4 | | | | | | (174) | | |
經營活動所用現金淨額
|
| | | | (21,745) | | | | | | | (26,080) | | | | | | (35,584) | | |
投資活動產生的現金流量: | | | | | | | | | | | | | | | | | | | | |
購買財產和設備
|
| | | | - | | | | | | | - | | | | | | (306) | | |
投資活動所用現金淨額
|
| | | | - | | | | | | | - | | | | | | (306) | | |
融資活動產生的現金流量: | | | | | | | | | | | | | | | | | | | | |
發行可轉換票據的收益
|
| | | | 14,000 | | | | | | | - | | | | | | 44,500 | | |
償還可轉換票據
|
| | | | - | | | | | | | - | | | | | | (3,992) | | |
融資活動提供的淨現金
|
| | | | 14,000 | | | | | | | - | | | | | | 40,508 | | |
現金及現金等值物淨(減少)增加
|
| | | | (7,745) | | | | | | | (26,080) | | | | | | 4,618 | | |
年初現金及現金等值物
|
| | | | 9,746 | | | | | | | 31,238 | | | | | | 5,128 | | |
期末現金及現金等值物
|
| | | $ | 2,001 | | | | | | $ | 5,158 | | | | | $ | 9,746 | | |
| | |
繼任者
|
| | |
前任
|
| ||||||
| | |
12月31日,
2023 |
| | |
12月31日,
2022 |
| ||||||
家具及固定裝置
|
| | | $ | 199 | | | | | | $ | 199 | | |
設備
|
| | | | 237 | | | | | | | 237 | | |
租賃物業裝修
|
| | | | 66 | | | | | | | 66 | | |
物業及設備
|
| | | | 502 | | | | | | | 502 | | |
累計折舊
|
| | | | (170) | | | | | | | (71) | | |
財產和設備,淨值
|
| | | $ | 332 | | | | | | $ | 431 | | |
| | |
12月31日,
|
| ||||||||||
| | |
2023
繼任者 |
| | |
2022
前任 |
| ||||||
法律費用
|
| | | $ | 1,867 | | | | | | $ | - | | |
消費稅責任
|
| | | | 569 | | | | | | | - | | |
經營租賃負債-短期部分
|
| | | | 278 | | | | | | | 257 | | |
大雄小瓶的使用
|
| | | | 33 | | | | | | | 202 | | |
剩餘其他應計費用
|
| | | | 843 | | | | | | | 281 | | |
其他應計費用總額
|
| | | $ | 3,590 | | | | | | $ | 740 | | |
截至2022年12月31日的年度(前身)
|
| | | | | | |
普通股股東可獲得的淨損失
|
| | | $ | (52,556) | | |
加權平均已發行普通股、基本股和稀釋股
|
| | | | 138,848,177 | | |
歸屬於普通股股東的每股淨虧損(基本和稀釋)
|
| | | $ | (0.38) | | |
2023年1月1日至2023年7月21日期間(前任)
|
| | | | | | |
普通股股東可獲得的淨損失
|
| | | $ | (60,678) | | |
加權平均已發行普通股、基本股和稀釋股
|
| | | | 138,848,177 | | |
歸屬於普通股股東的每股淨虧損(基本和稀釋)
|
| | | $ | (0.44) | | |
2023年7月22日至2023年12月31日期間(繼任者)(重述)
|
| | | | | | |
普通股股東可獲得的淨損失(重述)
|
| | | $ | (323,954) | | |
加權平均已發行普通股、基本股和稀釋股
|
| | | | 37,159,600 | | |
歸屬於普通股股東的每股淨虧損(基本和稀釋)
(As重述) |
| | | $ | (8.72) | | |
| | |
12月31日,
|
| ||||||||||
| | |
2023
|
| | |
2022
|
| ||||||
| | |
繼任者
|
| | |
前任
|
| ||||||
權證
|
| | | | 14,479,999 | | | | | | | - | | |
或然代價
|
| | | | 16,000,000 | | | | | | | - | | |
或有創始人股份
|
| | | | 3,450,000 | | | | | | | - | | |
已發行的可轉換優先股
|
| | | | - | | | | | | | 21,257,708 | | |
尚未發行的可轉換優先股證
|
| | | | - | | | | | | | 342,011 | | |
普通股期權和限制性股票單位
|
| | | | 4,888,537 | | | | | | | 9,694,890 | | |
| | | | | 38,818,536 | | | | | | | 31,294,609 | | |
自2011年起期間的合併經營報表和綜合損失
2023年7月22日至2023年12月31日(繼任者) |
| |
報告的
|
| |
調整
|
| |
經重列
|
| |||||||||
獲得在過程中的研發
|
| | | $ | - | | | | | $ | 348,000 | | | | | $ | 348,000 | | |
總運營成本和費用
|
| | | | (29,558) | | | | | | 348,000 | | | | | | 318,442 | | |
經營收入(損失)
|
| | | | 29,558 | | | | | | (348,000) | | | | | | (318,442) | | |
稅前收入(損失)
|
| | | | 24,046 | | | | | | (348,000) | | | | | | (323,954) | | |
淨利潤(虧損)和綜合收益(虧損)
|
| | | | 24,046 | | | | | | (348,000) | | | | | | (323,954) | | |
每股基本和稀釋淨利潤(虧損)
|
| | | $ | 0.65 | | | | | $ | (9.37) | | | | | $ | (8.72) | | |
可轉換優先股和股東赤字合併報表
2023年7月22日至2023年12月31日期間(繼任者) |
| |
報告的
|
| |
調整
|
| |
經重列
|
| |||||||||
累計赤字、截至2023年7月22日餘額(繼任者)
|
| | | $ | (180,856) | | | | | $ | 348,000 | | | | | $ | 167,144 | | |
淨利潤(虧損)
|
| | | $ | 24,046 | | | | | $ | (348,000) | | | | | $ | (323,954) | | |
期內簡明合併經營報表和全面虧損
2023年7月22日至2023年9月30日(繼任者)(未經審計) |
| |
報告的
|
| |
調整
|
| |
經重列
|
| |||||||||
獲得在過程中的研發
|
| | | $ | - | | | | | $ | 348,000 | | | | | $ | 348,000 | | |
總運營成本和費用
|
| | | | (64,286) | | | | | | 348,000 | | | | | | 283,714 | | |
經營收入(損失)
|
| | | | 64,286 | | | | | | (348,000) | | | | | | (283,714) | | |
稅前收入(損失)
|
| | | | 50,289 | | | | | | (348,000) | | | | | | (297,711) | | |
淨利潤(虧損)和綜合收益(虧損)
|
| | | | 50,289 | | | | | | (348,000) | | | | | | (297,711) | | |
每股基本和稀釋淨利潤(虧損)
|
| | | $ | 1.35 | | | | | $ | (9.36) | | | | | $ | (8.01) | | |
可轉換優先股和股東權益的簡明合併報表
2023年7月22日至2023年9月30日期間的赤字(繼任者)(未經審計) |
| |
報告的
|
| |
調整
|
| |
經重列
|
| |||||||||
累計赤字、截至2023年7月22日餘額(繼任者)
|
| | | $ | (180,856) | | | | | $ | 348,000 | | | | | $ | 167,144 | | |
淨利潤(虧損)
|
| | | $ | 50,289 | | | | | $ | (348,000) | | | | | $ | (297,711) | | |
|
合併中作為對價發行的股份數量
|
| | | | 16,500,000 | | |
|
與承諾融資相關的臨時可轉換票據發行的股份
|
| | | | 2,226,182 | | |
|
合併後公司普通股股數總數
|
| | | | 18,726,182 | | |
|
乘以截至收盤的Priveterra股價
|
| | | $ | 10.84 | | |
|
總
|
| | | $ | 202,992 | | |
|
或然代價之公平值
|
| | | | 125,699 | | |
|
取代股份支付獎勵
|
| | | | 13,331 | | |
|
承擔的負債
|
| | | | 125 | | |
|
總購買價格
|
| | | $ | 342,147 | | |
|
現金及現金等價物
|
| | | $ | 2,001 | | |
|
淨營運資本(不包括現金及現金等值物)
|
| | | | (16,182) | | |
|
其他資產及負債
|
| | | | 775 | | |
|
獲得在過程中的研發
|
| | | | 348,000 | | |
|
收購資產淨值
|
| | | | 334,594 | | |
|
VIE合併損失
|
| | | | 7,553 | | |
|
總購買價格
|
| | | $ | 342,147 | | |
| | | | | |
共同
股份 |
| |
共同
股票 量 |
| |
訂閱
應收 |
| |
APIC
|
| |
積累
赤字 |
| | | | |||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
(As重述)
|
| | |||||
截至2023年7月21日的Priveterra收盤股權
|
| | | | | | | 557,160 | | | | | $ | - | | | | | $ | - | | | | | $ | 5,937 | | | | | $ | (12,897) | | | | ||
合併中作為對價發行的股份
|
| |
注1
|
| | | | 16,500,000 | | | | | | 2 | | | | | | - | | | | | | 192,189 | | | | | | - | | | | ||
合併考慮-發行股份
與中期可轉換票據相關 承諾融資 |
| |
Note 7
|
| | | | 2,226,182 | | | | | | - | | | | | | - | | | | | | 24,132 | | | | | | - | | | | ||
b類創始人股份的股票補償
|
| |
附註5
|
| | | | 6,900,000 | | | | | | 1 | | | | | | - | | | | | | 68,972 | | | | | | (68,972) | | | | ||
遠期購買協議
|
| |
附註8
|
| | | | 6,275,000 | | | | | | 1 | | | | | | (60,710) | | | | | | 66,714 | | | | | | (38,255) | | | | ||
發行整體衍生品
|
| |
附註8
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | (427) | | | | ||
New Money PIPE認購協議中發行的股份
|
| |
附註8
|
| | | | 1,001,000 | | | | | | - | | | | | | - | | | | | | 10,844 | | | | | | (6,433) | | | | ||
為承諾發行的股份
融資 |
| |
附註8
|
| | | | 3,571,429 | | | | | | - | | | | | | - | | | | | | 38,714 | | | | | | (13,714) | | | | ||
或有創始人股份
|
| |
附註8
|
| | | | - | | | | | | - | | | | | | - | | | | | | (31,401) | | | | | | - | | | | ||
VIE合併損失
|
| |
附註5
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | | | | | (7,553) | | | | ||
其他雜項
|
| | | | | | | 128,829 | | | | | | - | | | | | | - | | | | | | 1,397 | | | | | | (1,397) | | | | ||
總 | | | | | | | | 37,159,600 | | | | | $ | 4 | | | | | $ | (60,710) | | | | | $ | 377,498 | | | | | $ | (149,648) | | | |
| | |
12月31日,
2023 |
| |
7月21日,
2023 |
| ||||||
股價
|
| | | $ | 7.20 | | | | | $ | 10.84 | | |
預期波幅
|
| | | | 52.00% | | | | | | 55.00% | | |
無風險利率
|
| | | | 4.48% | | | | | | 4.82% | | |
預期壽命(年)
|
| | | | 1.56 | | | | | | 2 | | |
預期股息率
|
| | | | - | | | | | | - | | |
| | |
可換股
注意到 (3級) |
| |
令
負債 (1級) |
| |
特遣隊
審議 (3級) |
| |
嵌入式
向前 購買 協議和 使整個 衍生物 (3級) |
| ||||||||||||
前任 | | | | | | | | | | | | | | | | | | | | | | | | | |
餘額,2022年12月31日
|
| | | $ | 131,292 | | | | | $ | - | | | | | $ | - | | | | | $ | - | | |
發行可換股票據
|
| | | | 14,000 | | | | | | - | | | | | | - | | | | | | - | | |
公平值變動
|
| | | | 19,359 | | | | | | - | | | | | | - | | | | | | - | | |
轉換為普通股
|
| | | | (164,651) | | | | | | - | | | | | | - | | | | | | - | | |
餘額,2023年7月21日
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | |
繼任者 | | | | | | | | | | | | | | | | | | | | | | | | | |
餘額,2023年7月22日
|
| | | | - | | | | | | 3,765 | | | | | | 157,100 | | | | | | 32,677 | | |
添加
|
| | | | - | | | | | | - | | | | | | - | | | | | | - | | |
公平值變動
|
| | | | - | | | | | | (2,318) | | | | | | (52,750) | | | | | | 8,366 | | |
餘額,2023年12月31日
|
| | | $ | - | | | | | $ | 1,447 | | | | | $ | 104,350 | | | | | $ | 41,043 | | |
| 各財年的最低租賃付款額 | | | | | | | |
|
2024
|
| | | $ | 292 | | |
|
未來最低租賃付款總額
|
| | | | 292 | | |
|
減:推定利息
|
| | | | (14) | | |
|
租賃付款現值
|
| | | | 278 | | |
|
減:流動部分(包括在其他應計費用中)
|
| | | | (278) | | |
|
非流動經營租賃負債
|
| | | $ | - | | |
|
經營租賃使用權資產
|
| | | $ | 262 | | |
|
剩餘租期(年)
|
| | | | 0.9 | | |
|
貼現率
|
| | | | 10% | | |
| | |
截至12月31日的一年,
|
| |||||||||||||||
| | |
2023
|
| |
2022
|
| ||||||||||||
| | |
前任
2023年1月1日至 2023年7月21日 |
| |
繼任者
2023年7月22日至 2023年12月31日 |
| |
前任
|
| |||||||||
經營租賃成本
|
| | | $ | 153 | | | | | $ | 122 | | | | | $ | 279 | | |
經營租賃支付的現金
|
| | | | 180 | | | | | | 129 | | | | | | 248 | | |
| | |
12月31日,
|
| |||||||||
| | |
2023
|
| |
2022
|
| ||||||
遞延所得稅資產: | | | | | | | | | | | | | |
應計報酬
|
| | | $ | 271 | | | | | $ | 296 | | |
應計其他費用
|
| | | | - | | | | | | 123 | | |
股票薪酬
|
| | | | 1,647 | | | | | | 5,303 | | |
啟動成本和其他無形資產
|
| | | | 12,230 | | | | | | 13,727 | | |
經營虧損淨額
|
| | | | 28,613 | | | | | | 20,131 | | |
租賃負債
|
| | | | 83 | | | | | | 157 | | |
其他遞延資產
|
| | | | 23 | | | | | | 32 | | |
資本化的研發費用
|
| | | | 11,264 | | | | | | 6,387 | | |
| | | | | 54,131 | | | | | | 46,156 | | |
減:估值津貼
|
| | | | (53,978) | | | | | | (45,929) | | |
遞延所得稅資產總額
|
| | | | 153 | | | | | | 227 | | |
遞延稅務負債: | | | | | | | | | | | | | |
折舊
|
| | | | (75) | | | | | | (89) | | |
ROU資產
|
| | | | (78) | | | | | | (138) | | |
遞延所得稅負債總額
|
| | | | (153) | | | | | | (227) | | |
淨遞延所得稅
|
| | | $ | - | | | | | $ | - | | |
| | |
12月31日,
|
| |||||||||
| | |
2023
|
| |
2022
|
| ||||||
法定稅率所得稅
|
| | | | 21.0% | | | | | | 21.0% | | |
可換股票據
|
| | | | (1.1) | | | | | | (1.8) | | |
或然代價
|
| | | | 2.9 | | | | | | - | | |
遠期購買協議
|
| | | | (1.0) | | | | | | - | | |
權證
|
| | | | 0.1 | | | | | | - | | |
股票薪酬
|
| | | | - | | | | | | (0.5) | | |
官員薪酬
|
| | | | (0.5) | | | | | | - | | |
交易成本
|
| | | | (0.8) | | | | | | - | | |
IPR & D
|
| | | | (19.0) | | | | | | - | | |
估值津貼變化
|
| | | | (1.4) | | | | | | (18.7) | | |
實際稅率
|
| | | | 0% | | | | | | 0.0% | | |
| | |
12月31日,
|
| |||||||||
| | |
2023
|
| |
2022
|
| ||||||
年初餘額
|
| | | $ | 11,061 | | | | | $ | 7,270 | | |
由於本年度稅收狀況而增加
|
| | | | 3,609 | | | | | | 3,791 | | |
由於上一年稅收狀況而減少
|
| | | | - | | | | | | - | | |
年底餘額
|
| | | $ | 14,670 | | | | | $ | 11,061 | | |
| | |
股份
授權 |
| |
發行股份
和傑出 |
| |
每股
偏好 |
| |
優惠
清算 值 (in數千) |
| |
攜帶價值,
扣除發行 成本 (in數千) |
| |||||||||||||||
系列 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
A輪
|
| | | | 7,393,333 | | | | | | 2,505,508 | | | | | $ | 5.4779 | | | | | $ | 13,725 | | | | | $ | 13,819 | | |
A-1系列
|
| | | | 4,107,414 | | | | | | - | | | | | | 5.4779 | | | | | | - | | | | | | - | | |
系列A-2
|
| | | | 4,846,750 | | | | | | 4,846,750 | | | | | | 5.4779 | | | | | | 26,550 | | | | | | 26,379 | | |
b輪
|
| | | | 20,520,678 | | | | | | 6,244,395 | | | | | | 7.3097 | | | | | | 45,645 | | | | | | 43,896 | | |
系列b-1
|
| | | | 136,805 | | | | | | - | | | | | | 7.3097 | | | | | | - | | | | | | - | | |
系列b-2
|
| | | | 7,661,055 | | | | | | 7,661,055 | | | | | | 7.3097 | | | | | | 56,000 | | | | | | 53,855 | | |
| | | | | 44,666,035 | | | | | | 21,257,708 | | | | | | | | | | | $ | 141,920 | | | | | $ | 137,949 | | |
| | |
12月31日,
|
| |||||||||
| | |
2023
|
| |
2022
|
| ||||||
可轉換優先股轉換
|
| | | | - | | | | | | 21,257,708 | | |
已發行和未行使的股票期權
|
| | | | 3,846,972 | | | | | | 9,694,890 | | |
限制性股票單位(未歸屬)
|
| | | | 1,012,994 | | | | | | - | | |
股票激勵計劃下可供未來發行的股票
|
| | | | 3,536,710 | | | | | | 27,884,000 | | |
權證
|
| | | | 14,479,999 | | | | | | - | | |
或然代價
|
| | | | 16,000,000 | | | | | | - | | |
尚未發行的可轉換優先股證
|
| | | | - | | | | | | 342,011 | | |
保留普通股總數
|
| | | | 38,876,675 | | | | | | 59,178,609 | | |
| | |
數量
股份 |
| |
加權
平均 行使 價格 |
| ||||||
前任 | | | | | | | | | | | | | |
傑出,2022年1月1日
|
| | | | 10,516,525 | | | | | $ | 1.51 | | |
授出購股權
|
| | | | - | | | | | | - | | |
期權被沒收
|
| | | | (821,635) | | | | | | 1.23 | | |
傑出,2022年12月31日
|
| | | | 9,694,890 | | | | | | 1.53 | | |
可撤銷,2022年12月31日
|
| | | | 9,694,890 | | | | | $ | 1.53 | | |
傑出,2023年1月1日
|
| | | | 9,694,890 | | | | | $ | 1.53 | | |
授出購股權
|
| | | | - | | | | | | - | | |
期權被沒收
|
| | | | - | | | | | | - | | |
因合併而取消的期權
|
| | | | (9,694,890) | | | | | | 1.53 | | |
傑出,2023年7月21日
|
| | | | - | | | | | | - | | |
可撤銷,2023年7月21日
|
| | | | - | | | | | $ | - | | |
| | |
數量
股份 |
| |
加權
平均 行使 價格 |
| ||||||
前任 | | | | | | | | | | | | | |
傑出,2022年1月1日
|
| | | | 38,172 | | | | | $ | 986.36 | | |
授出購股權
|
| | | | 16,437 | | | | | | 898.58 | | |
期權被沒收
|
| | | | (9,075) | | | | | | 965.92 | | |
傑出,2022年12月31日
|
| | | | 45,534 | | | | | | 958.75 | | |
可撤銷,2022年12月31日
|
| | | | 23,155 | | | | | $ | 958.86 | | |
傑出,2023年1月1日
|
| | | | 45,534 | | | | | $ | 958.75 | | |
授出購股權
|
| | | | - | | | | | | - | | |
期權被沒收
|
| | | | (404) | | | | | | 1,021.98 | | |
傑出,2023年7月21日
|
| | | | 45,130 | | | | | | 959.06 | | |
可撤銷,2023年7月21日
|
| | | | 30,968 | | | | | $ | 956.64 | | |
繼任者 | | | | | | | | | | | | | |
傑出,2023年7月22日(已轉換)
|
| | | | 3,515,219 | | | | | $ | 10.00 | | |
授出購股權
|
| | | | - | | | | | | - | | |
期權被沒收
|
| | | | - | | | | | | - | | |
傑出,2023年12月31日
|
| | | | 3,515,219 | | | | | | 10.00 | | |
可撤銷,2023年12月31日
|
| | | | - | | | | | $ | - | | |
| | |
數量
股份 |
| |
加權
平均 授出日期 公平值 |
| ||||||
繼任者 | | | | | | | | | | | | | |
傑出,2023年7月22日
|
| | | | - | | | | | $ | - | | |
授予
|
| | | | 1,169,366 | | | | | | 10.84 | | |
既得
|
| | | | (127,801) | | | | | | 10.84 | | |
沒收
|
| | | | (28,571) | | | | | | 10.84 | | |
傑出,2023年12月31日
|
| | | | 1,012,994 | | | | | $ | 10.84 | | |
| | |
數量
股份 |
| |
加權
平均 行使 價格 |
| ||||||
傑出,2023年7月22日
|
| | | | - | | | | | $ | - | | |
授出購股權
|
| | | | 331,753 | | | | | | 5.47 | | |
期權被沒收
|
| | | | - | | | | | | - | | |
傑出,2023年12月31日
|
| | | | 331,753 | | | | | $ | 5.47 | | |
可撤銷,2023年12月31日
|
| | | | - | | | | | $ | - | | |
| | |
12月31日,
|
| |||
| | |
2023
|
| |
2022
|
|
預期波幅
|
| |
57%
|
| |
47% - 61%
|
|
無風險利率
|
| |
4.1% - 4.4%
|
| |
1.87% - 3.92%
|
|
預期壽命(年)
|
| |
3.00-6.25
|
| |
5.75- 6.25
|
|
預期股息率
|
| |
-
|
| |
-
|
|